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Central to the progression of all organisms is the maintenance of a stable genome 
despite continuous insults arising from genotoxic and environmental stresses. Embryonic 
stem cells show promise for treatment of a variety of diseases as well as for providing 
normal human tissue to conduct scientific research.  A major obstacle for their application 
is that genomic instability arises in stem cells after prolonged cell culture. The most 
detrimental form of DNA damage is the DNA double-strand break (DSB), which is 
managed by cells through complex mechanisms, designated the DNA damage response.  
There are two major types of DSB repair; homologous recombination repair (HRR) and 
non-homologous end joining (NHEJ), both of which are regulated by members of the 
 xv
 phosphatidyl-inositol-3’-kinase-related kinase (PIKK) family, including Ataxia 
Telangiectasia Mutated (ATM), Ataxia Telangiectasia Mutated and Rad3-related (ATR) 
and the DNA dependent protein kinase (DNA-PK). 
 
The aim of this study was to define the mechanisms and important proteins involved in 
repair of human embryonic stem cells.  Here we have also described a system to 
differentiate hESCs into neural progenitors and astrocytes and were able to examine their 
DNA damage response. In both examining DNA repair markers and using a DNA repair 
reporter assay, this work shows that ATR is involved in DSB repair early in development, 
whereas ATM is essential in DSB repair in differentiated cells. We also show that HRR, a 
high fidelity form of repair, is used extensively by embryonic stem cells and HRR 
diminishes as cells differentiate.  We also further defined the extent of NHEJ and the role 
of high fidelity NHEJ from the embryonic to differentiated state.   
 
These findings further the basic knowledge of repair fidelity in embryonic and mature 
human tissue.  The data gives insight into what proteins maintain stem cell genomic 
stability and may be important to develop safe technologies for tissue engineering.  
Specifically, we have defined what DNA damage signaling pathways are used as 
embryologic cells progress to a mature, functional state. 
 xvi
  xvii 
 
  
 
 
 
 
 
 
Chapter 1. DNA Repair and Stem Cells 
 
 
 
 
Embryonic Stem Cells 
 
Embryonic stem cells (ESCs) are derived from the inner cell mass of an embryo 
and contain unique properties that differentiated cells do not.  These include a defining 
property called pluripotency, which describes their ability to form all three germ layers of 
the human body: the ectoderm, endoderm and mesoderm.  During embryonic development 
ESCs differentiate into adult stem cells and fully differentiated cells.  Adult stem cells or 
progenitor cells are said to be multipotent indicating that they can develop progeny of 
several different cell types including cardiac (Fleischmann et al. 1998), endothelial (Wang 
et al. 1992), or neuronal cells (Dhara et al. 2008a). Throughout differentiation cells gain 
more specialized functions. The final stage of differentiation is to form somatic cells from 
multipotent cells containing specialized functions such as neurons which transmit electrical 
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 signals or muscle cells acting as contractile tissue. These unique properties of stem cells 
indicate they are a potential tool for advancement in regenerative medicine, the 
understanding of developmental biology, drug development and other applications 
(Thomson et al. 1998). As stem cells replicate they are capable of either symmetric 
(clonogenic) or asymmetric fission (Figure 1-1). Symmetric division generates a self-renewing 
supply of pluripotent ESCs, while asymmetric division produces one cell identical to the parent 
ESC and a differentiated cell.  
 
ESCs are able to self renew indefinitely and there are several possible cellular 
processes that make this possible. Unlike somatic cells, ESCs maintain their telomere 
length indefinitely by expression of telomerase (Carpenter et al. 2004).    Senescence may 
also be avoided in ESCs by a mechanism dependent on a non-functional p53 pathway 
(Miura et al. 2004), or by fundamental differences in the ability of hESCs to prevent and 
repair DNA damage (Adams et al.; Maynard et al. 2008). 
 
 Telomeres are repetitive sequences containing the nucleotide sequence TTAGGG, 
which functions to preserve the structure of the end of each chromosome. Telomeres act as 
a capping mechanism that prevents the ends of the chromosomes from being chewed back 
by exonucleases and distinguishes them from double-strand breaks (Lundblad 2000).  As 
cells divide the length of the telomere decreases unless the cells express telomerase which 
extends these structures.  Telomerase is expressed in ESCs, germ line cells,  
 2
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 and cancer cells but not in somatic cells. Since it is not expressed in somatic cells the 
telomere shortens and may act as a clock to signal when cells should stop dividing.   
 
The p53 transcription factor has also been shown to be important in differentiation 
and may act as a negative regulator of pluripotency.  p53 is known as the “guardian of the 
genome” and regulates genomic stability and growth through several mechanisms.  p53 
can stimulate DNA damage response, induce cell cycle arrest at the G1/S transition, or 
initiate apoptosis, a mechanism for programmed cell death (Abraham 2001). In examining 
a role in differentiation it was shown that p53 can control transcription of the genes 
required for ESC self renewal (Lin et al. 2005; Maimets et al. 2008). Importantly increased 
expression of p53 may mediate differentiation whereas its knockdown can help lead to 
dedifferentiation of somatic cells (Hong et al. 2009).  A recently generated p53 hESCs 
knockout line has been generated and shown to diminish the G2/M checkpoint indicating a 
role in genetic stability (Song et al.). 
 
ESCs sustain their pluripotency and bypass senescence unlike somatic cells and an 
explanation for this is these cells are able to maintain their genomic and epigenetic 
integrity to a higher degree than somatic cells (Hong et al. 2007). However the effects of 
stress such as radiation, hypoxia, and stress-induced senescence on human ESCs (hESCs) 
are not clearly defined.  
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 It was not until recently that the isolation of hESCs from the blastocysts was 
successfully performed and these cells could be propagated in vitro (Thomson et al. 1998). 
For this reason the DNA damage response has only been studied in immortalized somatic 
cells and cancer cells.  Investigating repair in these cells is important since ESCs form all 
tissues of the embryo indicating that these few cells must stringently avoid any 
proliferation of mutations arising during embryogenesis. 
 
 
DNA Damage and Repair 
 
DNA damage can be caused by a variety of endogenous and exogenous agents 
including UV light, chemical carcinogens, reactive oxygen species, chemotherapeutic 
reagents and various forms of radiation (Hall 2000,(Norbury and Hickson 2001).  Harmful 
agents cause many different forms of DNA damage as well.  Each of the nucleic acid bases 
can be covalently modified at various positions leading to base substitutions and alterations 
of the genetic code.  A DNA strand can also covalently bind itself or the opposite strand, 
which is known as intrastrand and interstrand cross-linking, respectively. Here, mistakes 
are made during the DNA replication leading to improper base pairing, deletions or 
insertions.   Also, the backbone strand itself can be broken leading to either single-strand 
or double-strand breaks.  Repair of each form of damage can be accomplished by specific 
cellular processes with the possibility of overlap between proteins used in each mechanism 
(Jackson 1996; Matsuoka et al. 2007).  
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When a cell endures DNA damage there is a multifaceted response to counter the 
effects of damage.  Once the genomic injury has been detected several cell cycle 
checkpoints are activated to prevent further progression in order to allow time for repair 
before further cellular division. Here the decision is made to either repair the damage or 
undergo apoptosis (Norbury and Hickson 2001).  Therefore, the DDR can stimulate or 
inhibit gene transcription of major DNA repair and apoptotic proteins depending on the 
level of the damage.  
 
 The DNA checkpoints utilize sensor proteins as the initial signaling elements that 
respond to strand breaks, partially replicated DNA and base modifications (Jackson 1996). 
These sensors quickly moderate the actions of downstream proteins.  Human cells contain 
three well classified proteins implicated in damage sensing from the phosphatidyl-inositol-
3’-kinase-related kinase (PIKK) family of proteins.  These proteins are ataxia 
telangiectasia mutated (ATM), ATM and Rad3-related (ATR) and DNA dependent protein 
kinase (DNA-PK)(Jackson 1996).   
 
ATM and ATR are thought to share responsibilities as the apical protein kinases in 
all of the known cell cycle checkpoints. These proteins share sequence homology in the 
catalytic domains as well as a similar overall structural organization (Abraham 2001). Both 
of these proteins contain FAT/FATC domains which do not correlate to any known 
catalytic domain, however they most likely regulate intramolecular conformation. An 
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 analysis of proteins phosphorylated in response to DNA damage shows conserved sites 
recognized by ATM and ATR.  Interestingly the p-(S1981)ATM antibody has been shown 
to identify multiple proteins due to the conserved sequence that is phosphorylated by both 
ATM and ATR, therefore the p-ATM antibody may recognize substrates downstream of 
ATR as well (Matsuoka et al. 2007).   
 
While ATM and ATR share many responsibilities, understanding the checkpoint 
responses can begin to separate each kinase’s role in genomic stability.  The G1 checkpoint 
is controlled by p53.  When p53 is phosphorylated at serine 15 it upregulates p21, a cyclin 
dependent kinase inhibtor that suppress cyclin E/A, which cause the G1 to S transition 
(Figure 1-2).  ATM has been shown to be responsible for the early response and the initial 
activation of p53, whereas ATR may aid in maintenance of p53 activation at later time 
points, however ATR is less significant in this pathway.  It is also important to note that 
ATM activates CHK2 which relays the signal for MDM2 to release p53 in order for the 
checkpoint to be robust.  
 
The S-phase checkpoint is signaled through several mechanisms including one in 
which ATM activation leads to the proteosome-mediated degradation of Cdc25A and then 
failure to maintain activation of cyclin complexes thereby halting synthesis.  ATR’s role in 
this checkpoint is associated with signaling after replication fork stalling.  Here ATR may 
activate a variety of factors including Chk1 and Rad protein family members, which detect 
and act as scaffolding at points of DNA damage.   
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Figure 1-2. Cell cycle checkpoint control after DNA damage. 
Several checkpoints are initiated through cell signaling mechanisms 
allowing the cell time to repair itself or induce apoptosis.  The three 
main cell cycle checkpoints occur at the G1/S transition, within S 
phase, and at the G2/M transition. Adapted from Robert Abraham 
(2001) 
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   The G2 checkpoint utilizes ATR and Chk1 as its central signaling mechanisms.   Initiation 
of the G2/M checkpoint begins with activation of Chk1, which phosphorylates the mitosis-
promoting phosphatase, Cdc25C. Phosphorylation of Cdc25C by pCHK1 creates a binding 
site for 14-3-3 proteins ultimately inactivating Cdc25C. Therefore Cdc25C is unable to 
dephosphorylate and hence activate cyclin B·Cdc2 kinase, a complex responsible for G2 to 
M progression. Deficiency in any of these proteins responsible for sensing or relaying the 
DDR will lead to cancer predisposition (Thompson and Schild 2002).   As mentioned 
previously ATM and ATR kinases have some functional redundancy and are possibly able 
to signal through each checkpoint in the absence of the other.  Notably A-T cells, which 
have a nonfunctional ATM protein, exhibit strong G2 checkpoint arrest regardless of the 
type of damage. This indicates ATM is not essential for the G2 checkpoint and likely points 
to ATR for policing this checkpoint (Beamish and Lavin 1994). 
  
 
 
Double-Strand Break Repair 
 
It has become increasing clear that the most detrimental form of damage to DNA is the 
double-strand break (DSB) (Iliakis 1991). Accordingly, one DSB may lead to cell death if 
left unrepaired (Dasika et al. 1999). It is important to note that normal metabolic 
intermediates and stalled replication forks can induce these breaks. In fact, DSBs are  
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Figure 1-3. DNA-PK-dependent (D-NHEJ) and DNA-PK-
independent/Backup NHEJ (B-NHEJ)  Adapted from Valerie and 
Povirk (2003) and Iliakis (2009)  
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 needed in the normal physiological cellular processes in the production of antibodies 
during V(D)J recombination (Bassing et al. 2002).  
 
Essential to the cell are two forms of DNA DSB repair referred to as non-
homologous end joining (NHEJ) and homologous recombination repair (HRR). NHEJ 
represents in its simplest form an error-prone repair of the DNA break and is the 
predominant type of DSB repair in mitotically dividing cells. NHEJ begins with the 
KU70/KU80 heterodimer binding to the DNA ends which recruits the catalytic subunit of 
DNA-dependent protein kinase (DNA-PKcs). The ends are resected by the Artemis and 
MRE11/RAD50/NBS1 (MRN) nucleases, followed by XRCC4, XLF and DNA ligase IV 
recruitment for resealing (Povirk 2002; Valerie and Povirk 2003; Ito et al. 2004) (Figure 
1-3). Also the utilization of this dominant pathway of NHEJ (D-NHEJ) may allow for 
enzymes such as polymerases µ and λ to fill in nucleotide overhangs and ensure a higher 
accuracy of repair (Akopiants et al. 2009). 
 
New evidence is further defining backup NHEJ (B-NHEJ) pathways and indicates 
there are multiple signaling components. NHEJ may utilize a dominant pathway with the 
components previously mentioned including DNA-PKcs, Ku 70/80 and LigIV/XRCC4, 
while a backup pathway may utilize Histone H1, Poly (ADP-ribose) polymerase 1 (PARP-
1), and a Ligase III/XRCC1 complex (Figure 1-3).  Through knockout studies in MEFs it 
appears the back-up pathway for NHEJ has slower repair kinetics (Iliakis 2009) and occurs 
in the S/G2 phase of the cell cycle (Iliakis 2009).   Current models show that Ku70/80 
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 binds DNA DSBs with higher affinity and faster kinetics than components of the back up 
pathway, thereby inhibiting this process (Wang et al. 2006).  However, when the dominant 
DNA-PKcs dependent form fails due to low levels of essential protein components or 
changes in chromatin structure, the back-up pathway is utilized.  Also the utilization of the 
backup pathway with slower kinetics may allow for enzymes such as polymerases µ and λ 
to fill in nucleotide overhangs and ensure a higher accuracy of repair. There is current 
speculation high fidelity NHEJ may be more common in S or G2 cells due to the presence 
of a sister chromatid. There is data showing close physical cohesion of sister chromatids 
might play an important role in stabilizing the ends of the DSB and preventing degradation 
or exonuclease activity that may lead to deletions (Miyazaki and Orr-Weaver 1994).    
 
Homologous recombination repair uses a DNA template, either in the form of a 
sister chromatid, homologous chromosome or repeated sequence, to ensure high-fidelity 
repair. This mechanism involves a large number of proteins, including RAD51, its paralogs 
(XRCC2, XRCC3), RAD52, RAD54, BRCA1, BRCA2, and the MRE11/RAD50/NBS1 
complex (Karran 2000; Thompson and Schild 2001) (Figure 1-4). After the break there is 
resection of the DNA on each side of the DNA duplex.  RAD51 then binds this single-
stranded DNA and this complex begins “strand invasion,” a term signifying the search for 
a homologous sequence. After strand invasion a polymerase will extend the invading 
strand and form what is known as a Holliday Junction.  After cleavage of the Holliday 
junction DNA synthesis occurs to restore the strand on the homologous chromosome that 
was displaced during the strand invasion.  Whereas NHEJ can occur throughout the cell  
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Figure 1-4. Homologous Recombination Repair.  Adapted from 
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 cycle, it is believed that NHEJ is predominant in G1, whereas HRR is predominant during 
late S and G2 phases when sister chromatids are available (Rothkamm et al. 2003).   
 
Ionizing Radiation 
 
Ionizing radiation (IR) consists of subatomic particles that are able to detach 
electrons from atoms or molecules.  The ability of electromagnetic radiation to ionize 
particles depends upon its wavelength, hence the energy it carries (Camphausen and Coia 
2009).  Paradoxically, IR can induce cancer as well as be used to cure it and while 
radiation has many effects on the cell, the most significant biological target is the DNA.  
Radiation doses are defined as the energy absorbed per unit mass which is equivalent to 1 
J/kg and given the name Gray (Gy). Depending on the form of radiation the particles can 
have direct action on DNA or indirect actions by the formation of hydroxyl radicals, which 
contain an unpaired electron eager to react with another molecule (Hall 2000).  Notably as 
cells differentiate or proliferate at slower rates they become more radioresistant (Figure 1-
5). 
 
DNA Damage Response Proteins 
 
ATM, ATR and DNA-PKcs, represent proteins that are crucial for preventing the 
acceleration of aging, senescence, premature death and are associated with the 
maintenance of telomeres and genomic stability (Wong et al. 2003; Espejel et al. 2004).  
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Figure 1-5. Relative sensitivity of cells and tissue or 
organ to ionizing radiation. Sensitivity to ionizing 
radiation is proportional to proliferation rates.  Adapted 
from Hall (2000) 
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 Mutation of each of these proteins helps define what roles they may play in the human 
body. 
 
Mutation of the ATM gene leads to the disease A-T, which is characterized by 
immunodeficiency, a wobbly gait, cancer sensitivity and sterility (Shiloh 1997).  These 
cells are most notable for their high radiation sensitivity (Dasika et al. 1999).   ATR is an 
essential gene indicating the embryo will not survive with it being absent (Brown and 
Baltimore 2000).  When ATR is mutated at specific residues that lead to a splicing 
deficieny and therefore a decreased amount of the normal protein, a disease named Seckel 
syndrome results (O'Driscoll et al. 2003). This disease is characterized by growth 
retardation and “bird like” features with many phenotypes related to premature aging.   
Also, individuals with DNA-PK mutations experience severe combined immunodeficiency 
with an absence of B and T cells and similar to A-T patients these individuals also have 
sensitivity to IR (Collis et al. 2005).   
  
PARP-1 binds to DNA at certain damage sites and catalyses the formation of 
polyADP-ribose (PAR) on itself and other acceptor proteins (Lindahl et al. 1995). PAR 
formation is believed to alter chromatin structure, protect sites of DNA breaks and attract 
repair proteins. While knockout of either ATM or PARP-1 by themselves does not result in 
lethality, there is lethality when there is dual knockout of these genes.  This suggests that 
these genes may act in parallel pathways or backup to each other when DNA is faced with 
harmful DNA breaks.  It has also been  shown that ATM and DNA-PK function on the 
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 same pathway to ensure cellular survival in the absence of the PARP-1 gene (Bryant and 
Helleday 2006).  
 
Regenerative Medicine  
 
Although stem cell transplantation may offer treatments for many debilitating 
diseases, some concerns have been raised over its safety.  A major problem when 
propagating human embryonic stem cells (hESCs) in vitro is the inability to preserve 
genomic stability. Several reports show that hESCs propagated in vitro for even a few 
months can develop an abnormal karyotype (Buzzard et al. 2004; Draper et al. 2004).  
Avoiding chromosomal rearrangements and mutations is imperative for tissue engineering 
and human therapy with cells derived from embryonic or adult stem cells. This has become 
apparent by reports of donor derived leukemia after hematopoetic stem cell transplant as 
well as brain tumors due to implanted neural stem cells (Eguchi et al. 2001; Amariglio et 
al. 2009).  This technology is clinically promising yet detrimental when the cells do not 
maintain genetic stability. Embryonic stem cells seem to have unique properties when it 
comes to the DNA damage response (DDR) and DNA repair critical for maintaining 
genomic stability. Thus, it is very important to understand these properties in ESCs and 
neural progenitor (NPs) cells to ensure that cells are faithfully propagated in vitro for 
human tissue regenerative purposes. 
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Chapter 2 Neural Differentiation of Human Embryonic Stem Cells 
 
 
 
 
 
Introduction 
 
Human embryonic stem cells have recently been isolated from the human 
blastocyst and been shown to grow in culture while maintaining their pluripotency 
(Thomson et al. 1998). There has been a strong interest in developing methods to direct 
these cells down a specific cell lineage in order to obtain a virtually endless supply of 
functional human primary cells.  Recent reports have explained methods for directing these 
cells down to neural progenitors (NPs) (Dhara et al. 2008b). Similarly other investigators 
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 have shown the ability to grow in vivo derived NPs in cell culture and differentiate them to 
astrocytes in vitro (Seth et al. 2004).  Here we examined the proper markers for hESCs as 
the cells were guided to NPs and astrocytes as well as neurons.  Similarly we show that 
there is a loss in proliferation once cells have reached terminal differentiation.   
 
Characterization of hESCs can be performed through staining of different proteins 
involved in pluripotency.  Oct3/4 is a transcription factor within the cell nucleus controlling 
key pathways involved in proliferation and pluripotency. It has been shown to be quickly lost 
by differentiating hESCs and is the standard to monitor the maintenance of pluripotency in in 
vitro conditions (Pan et al. 2002).  When losing pluripotency, the cells must commit down a 
lineage to form a specific precursor cell from one of the three germ layers.  NPs can be 
identified by maintenance of the markers Nestin, Musashi-1 and Sox2. Nestin is expressed 
during development and is down regulated into adulthood in all cells except for those in 
the subventricular zone in the brain. This portion of the brain is where NPs reside and 
divide. As an exciting step towards regenerative therapy hESC derived NPs can be 
implanted in mouse brains, migrate along developmental tracks in the brain, differentiate, 
and use local cues to participate in the normal brain (Reubinoff et al. 2001).  NPs in the 
subventricular zone express Nestin which is a type VI intermediate filament protein 
replaced upon differentiation by other tissue-specific intermediate filament proteins.  Sox2 
is a transcription factor controlling many of the genes involved in multipotency and is 
expressed in NPs and hESCs. Notably to distinguish NPs from hESCs there is an increase 
in the expression of Musashi-1 as cells progress to NPs and a decrease after terminal 
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 differentiation.  Musashi-1 is a RNA binding protein that helps maintain multipotency by 
many mechanisms including regulating Notch signaling, a pathway involved in differentiation  
(Sakakibara et al. 1996; Okano et al. 2005).  
 
Astrocytes have many roles in the central nervous system. These roles include 
structural support, contribution to the blood-brain barrier, and nervous system repair. They also 
are involved in neural transmitter reuptake in order to regulate the ionic balance, which 
preserves neuronal health (Anderson and Swanson 2000; Wilczynska et al. 2009).  These 
cells express glial fibrillary acidic protein (GFAP) which replaces Nestin as an intermediate 
filament (Pekny and Pekna 2004).  GFAP’s function is not clearly delineated; however it is 
believed to be involved in mechanical strength and maintaining the shape of astrocytes.  
 
NPs also have the ability to differentiate into neurons and oligodendrocytes.  Neurons 
transmit information and react to stimuli through electrochemical signaling and 
neurotransmitter release while oligodendrocytes function to myelinate axons thereby 
improving signal transduction.  Neurons can be identified by a cytoskeletal protein called β-III 
tubulin, while mature oligodendrocytes are distinguished by expression of O1 protein (Sommer 
and Schachner 1981).   As cells reach terminal differentiation several phenotypic changes will 
result including a decrease in the nuclear to cytoplasmic ratio and the development of 
cytoplasmic extensions (Wilczynska et al. 2009).  
 
As cells progress through differentiation there will also be a loss in cell 
proliferation (Nieoullon et al. 2005).  Experimentally, in order to validate a decrease in 
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 growth 5-bromo-2-deoxyuridine (BrdU) can be used, which is a synthetic nucleoside 
analogue of thymidine. BrdU is incorporated into newly synthesized DNA as cells progress 
through DNA synthesis in the place of thymidine. Antibodies directed against BrdU can 
then be used to detect the incorporated chemical and thus quantify cells that were actively 
replicating their DNA.  
 
Materials and Methods 
 
Antibodies and reagents 
 
Antibodies used were anti-Oct3/4 and anti-β-actin from Santa Cruz Biotechnology 
(Santa Cruz, CA), anti-Nestin, anti-GFAP, anti-Musashi1, anti-βIII tubulin, anti-O1 and 
anti-Sox2 from Chemicon/Millipore (Billerica, MA), and anti-BrdU from Abcam.   
 
Cell culture and treatments 
 
BGO1V cells are embryonic stem cells that are easier to culture than BGO1 cells 
without inadvertently causing cell differentiation. They are a derivative of BG01 cells with 
karyotypic abnormalities (49, +12, +17 and XXY) which retain embryonic stem cell 
markers and characteristics, and the ability to differentiate down a neural lineage (Dhara et 
al. 2009). Differentiation was performed to according to published protocols to obtain 
populations of NPs and astrocytes (Fig. S1) (Adams et al.; Lawrence et al. 2006; 
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 Wilczynska et al. 2009). Briefly, BG01V cells were cultured in ES medium as described in 
(Shin et al. 2006; Wilczynska et al. 2009) consisting of Dulbecco’s modified Eagle’s 
medium (DMEM)/F12 medium (GIBCO, Grand Island, NY) supplemented with 20% 
knockout serum replacement (KSR) (GIBCO), 2 mM L-glutamine, 0.1 mM non-essential 
amino acids, 50 U/ml penicillin, 50 µg/ml streptomycin, 0.1 mM β-mercapto-ethanol, and 
5 ng/ml basic fibroblast growth factor (b-FGF) (R & D Systems, Minneapolis, MN). Cells 
were expanded on dishes of lysed MEF feeders (Gospodarowicz et al. 1980). 
 
Derivation of NPs was performed as described (Shin et al. 2006). Briefly, NP cells 
were grown on laminin coated dishes in DMEM/F12 medium containing 15% FBS and 5% 
KSR followed by an additional 7 days in media containing (DMEM/F12, N2 supplement 
(GIBCO), penicillin/streptomycin, L-glutamine, 5 ng/mL of b-FGF, and 10 ng/mL 
leukemia inhibitory factor (LIF). The cells were cultured in DN2 media for an additional 7 
days to obtain the NP population. NPs were propagated on poly-ornithine- and laminin-
coated plates in Neurobasal A Medium (GIBCO) supplemented with B-27 (GIBCO), L-
glutamine, and penicillin/streptomycin, 20 ng/mL b-FGF, and 10 ng/mL of LIF. Astrocytes 
were obtained by exposure of NPs to DMEM and FBS for 25 days on laminin-coated 
plates as described (Lawrence et al. 2006; Wilczynska et al. 2009). 
 
 
BrdU Staining  
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 Cells were grown on glass chamber slides. After the specified time of exposure to 
BrdU, cells were fixed with 3% paraformaldehyde for 15 min at room temperature. Cells 
were exposed to 2 N HCl for 30 min at 37oC, washed with PBS and a neutral pH was 
established by incubation with 0.8 M Borax for 10 min at RT. Cells were permeabilized 
with 0.5% Triton X-100  and then blocked with 0.5% goat serum in 10% milk followed by 
the addition of anti-BrdU antibody (1:100) to each chamber and rocked at +4oC overnight, 
washed, and incubated with secondary anti-rat Alexa 488 antibody (1:500). Finally, cells 
were washed in PBS and nuclei counter-stained with 4',6-diamidino-2-phenylindole 
(DAPI).  
 
 
Immunocytochemistry  
 
Immunocytochemistry (ICC) imaging has been described previously (Golding et al. 
2007). Cells were grown on Lab-Tek (Naperville, IL) glass slides. After treatment, cells 
were fixed with 3% paraformaldehyde for 15 min at RT, permeabilized with 0.5% Triton-
X-100 in phosphate-buffered saline (PBS) for 10 min at RT and blocked with 10% non-fat 
dry milk/0.5% goat serum/PBS prior to exposure to primary antibodies.  Subsequently, 
cells were incubated with primary antibodies at dilutions of 1:500 or isotype control 
nonspecific sera (Chemicon) overnight at 4°C in the blocking solution, followed by 
incubation with secondary antibodies Alexa 488 goat anti-rabbit or goat anti-mouse 546 
F(ab) fragment (Invitrogen) at 1:500 dilution, and nuclei counter-stained with DAPI at 1 
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 μg/mL. Cells were imaged and analyzed using a Zeiss LSM 510 Meta imaging system in 
the Massey Cancer Center Flow Cytometry and Imaging Facility with 63x or 100x 
objectives using the appropriate laser excitation of 405, 488, or 543 nm depending on the 
secondary antibody used.  Band pass filters for these three channels used were 420-480 
nm, 505-530nm, and 549-613 respectively.  A 0.5 µm slice of the nuclei was taken. 
Resolution of the images was set at 1044x1044 pixels per image.   
 
 
Results 
 
BG01V cells differentiate down a neural lineage to form neural progenitors and then 
astrocytes. 
 
 hESCs, NPs and astrocytes were propagated and examined for differentiation 
markers. The hESCs were positive for Sox2, Nestin, slightly positive for Musashi-1, and 
negative for GFAP.  >95% of these hESCs were positive for Oct3/4 (Figure 2-1). These 
proteins correctly stained for by antibodies and located in the cell’s nucleus or the 
cytoplasm according to each proteins function as transcription factors (nucleus), mRNA 
binding protein (cytoplasm) or as cytoskeletal proteins (cytoplasm).  This can be observed 
as either co-staining with the nucleus (DAPI) or as staining around the nucleus signifying 
the cytoplasm.  90% of the NPs stained positive for Sox2, Nestin, and Musashi-1 and were 
negative for Oct3/4 and GFAP (Figure 2-1).  The astrocytes were slightly positive for  
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Figure 2-1.  BG01V cells are directed down a neural lineage to 
form neural progenitors and terminally differentiated astrocytes. 
(A) hESCs, (B) NPs and (C) astrocytes were incubated with the 
indicated antibodies. Top row in each set shows staining without 
DAPI and bottom row the same fields with DAPI. 
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 Musashi-1 and negative for all other markers except around 95% of the cells were positive 
for GFAP (Figure 2-1).   
 
This directed differentiation protocol produces cells with other phenotypic 
characteristics of astrocytes.  As cells progress from hESCs to NPs and then to astrocytes 
there is a significant increase in the amount of glutamate uptake by the cells.  Also there is 
increased mRNA expression of GFAP and SPARCL1, which again are markers for 
terminally differentiated astrocytes (McKinnon and Margolskee 1996; Wilczynska et al. 
2009).  Also as cells become astrocytes they obtain cytoplasmic projections and a decrease 
in the nuclear to cytoplasmic ratio.  
 
 
Neural progenitor’s differentiation into neurons or oligodendrocytes is insignificant.  
 
It has been well established that hESCs can be differentiated into NPs (Shin et al. 
2006). However in vitro differentiation of NPs to astrocytes had previously only been 
performed on in vivo derived progenitor cells. Therefore it was necessary to quantify what 
percentage of NPs were differentiating into the other CNS cells besides astrocytes. We 
examined whether the cells were forming neurons or oligodendrocytes by staining with the 
neuronal marker β-III tubulin and the oligodendrocyte marker O1.   The differentiation 
shows only 1-2% of cells differentiate into neurons which contain a different morphology  
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Figure 2-2.  BG01V cells do not differentiate into neurons and 
oligodendrocytes.  Cells were stained for the marker βIII-tubulin 
(neuronal specific) and for O1 (oligodendrocyte-specific). To  
demonstrate the presence of βIII-tubulin+ cells a non-representative 
field of the population is displayed.  
O1 β III Tubulin
DAPI/O1 DAPI/β III Tubulin
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 than the astrocytes.  β-III tubulin positive cells are flat with extended projections like 
astrocytes, except these cells contain curled over nuclei (Figure 2-2) The differentiation 
scheme did not produce any oligodendrocytes which is shown by the lack of O1 protein 
expression. 
 
Cells lose the ability to proliferate after differentiation 
 
To determine the proliferation rate of hESCs and astrocytes cells were incubated 
with BrdU and its uptake was monitored to analyze cell proliferation. Here we are able to 
see that in only 6 hrs of incubation roughly 40-60% of the hESCs have been in or are in S 
phase.  However after 6 hours of incubation of astrocytes approximately 3-4% of the cells 
incorporate BrdU (Figure 2-3).  Therefore there is a drastic decrease in the proliferation 
rates from the early embryonic stage to the mature differentiated cells.  
 
Discussion 
 
Understanding the processes controlling neural cell differentiation may have 
critical consequences for therapies of brain tumors and regenerative medicine. Although 
research on the aspects DNA repair in mammal ESCs provides understanding of the 
processes, many differences exist between the human system and rodents including 
expression levels of major repair enzymes, repair kinetics and the efficiency of the DNA  
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 damage checkpoints (Hornsby 2003; Banuelos et al. 2008). Here we combined several 
protocols in order to generate NPs and then astrocytes in vitro from hESCs.  
 
The hESCs showed the correct staining for the pluripotent marker Oct3/4 defining 
its ability to form any cell of the three germ layers, as well as several other markers for 
multipotency. Similarly, NPs were identified by maintenance of these markers except for 
the loss of Oct3/4 and gain of Musashi-1.  Astrocytes were obtained at hiugh levels as 
denoted by GFAP+ staining. 
 
There is also a strong correlation between differentiation and the loss of the ability 
to proliferate.  Here through BrdU staining it is possible to see that virtually none of the 
astrocytes are in S phase.  It is also likely that the very small percentage of cells, 3-4%, that 
are dividing are astrocytic or glial precursor cells.  It was important to check whether there 
is variation into which cell types glial precursor cells would differentiate.  O1 and β-III 
tubulin staining showed that these cells were not forming neurons or oligodendrocytes.  It 
is possible to generate a higher percentage of neurons from the NPs but they must be 
exposed to additional growth factor during the differentiation process (Zhang et al. 2001).   
It also important the DNA repair assays used in this work require flat nuclei in vitro to 
track the resolution of DNA damage therefore the neuronal cells, which contained folded 
nuclei, could not be used.    
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 Altogether, relatively pure populations of hESCs (>95%), NPs (>90%), and 
astrocytes (>95%), were isolated and propagated. Importantly the cells show phenotypic as 
well as functional property of astrocytes such as glutamate uptake (Wilczynska et al. 
2009).  With these relatively pure populations of astrocytic cells at three different points of 
development we are able to then study the important aspects of DNA repair in models of 
early embryologic tissue to mature adult CNS tissue.      
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Chapter 3 DNA Damage Responses in hESCs 
 
 
 
 
Introduction  
 
Several studies show there is an increased importance for HRR early in 
development. Initial attempts to study such consequences were hindered by the embryonic 
lethality of knocking out a number of genes expressing proteins critical for HRR. The 
developmental significance was first displayed by knocking out RAD54, a protein 
involved in HRR, in mice which became sensitive to IR at the embryonic stage but not at 
the adult stage (Essers et al. 2000).  Interestingly, DNA-PKcs-deficient SCID mice become 
hypersensitive to IR when crossed with RAD54-/- mice. More recently, mice with the 
critical HRR factor XRCC2 deleted also showed embryonic lethality and significant 
apoptosis early in fetal development (Orii et al. 2006). The apoptotic events in these mice 
were exclusively located in the ventricular zone where neural stem cells develop. Also, 
mice deficient in Ligase IV, essential for NHEJ, showed no significant consequence until 
mid- to late-stages of embryonic development. Unlike XRCC2-/- mice, those cells that 
 showed apoptotic events stained positive for a marker indicating they were undergoing 
differentiation (Orii et al. 2006). Also from these studies, it was determined that MEFs 
derived from XRCC2-/- mice exhibit spontaneous chromosomal rearrangements in culture 
(Orii et al. 2006)..  Altogether, these studies suggest that HRR is critical during early 
development, whereas NHEJ is more important at later stages.  Because the repair 
pathways have such an imperative role in determining whether a cell will reach a 
functional and physiologic state as it differentiates, it was important to examine kinetics of 
DNA repair throughout differentiation.   
 
Our laboratory utilizes ionizing radiation (IR) as a method for induction of DSBs. 
Several antibodies will be used to verify the repair efficiency of irradiation induced foci 
(IRIF), which represent the collection of repair proteins at the site of a double-strand break.  
dEpigenetic alteration of histone variant 2AX by phosphorylation at serine 139 is one of 
the earliest signs of formation of DSBs (Rogakou et al. 1998). This alteration is designated 
γ-H2AX.  This marker can define one DSB and yield over 2000 γ-H2AX molecules with 
the chromatin modified up to 2 megabases away from the damage site.  It is important to 
note that H2AX phosphorylation occurs during mitosis and apoptosis in both normal 
human and cancer cell lines indicating that on rare occasion it may not signal for a DSB 
(Rogakou et al. 2000).  While this phenomenon has yet to be observed in stem cells other 
DNA repair proteins that are involved in foci formation must be examined to validate any 
conclusions.  
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 In order to specifically look at HRR repair foci RAD51 localization can be 
examined since this protein plays a pivotal role in the HRR pathway. RAD51 is a 
scaffolding protein that has been shown to colocalize with both tumor suppressor proteins 
BRCA1 and BRCA2 in DNA-damage-induced foci. Studies have shown that HRR is a 
delayed process and for this reason it is important to examine foci repair at time points up 
to 24 hrs.  53BP1 represents a factor involved in the DNA DSB repair response forming 
foci that colocalize with γ-H2AX within 5 minutes of IR treatment (Schultz et al. 2000). 
The recruitment of 53BP1 is independent of ATM, however it does require the 
phosphorylation of histone 2A (Ward et al. 2003). DNA-PKcs represents the core complex 
of proteins responsible for NHEJ and we have currently utilized an anti-p-(T2609) DNA-
PK to determine the presence of IRIF in glioma cells (Golding et al. 2009a).  The use of 
several antibodies to repair foci is an efficient manner in validating their resolution and for 
depicting which repair process may be more prevalent.  
  
These assays will establish which form of DSB repair is occurring and at what rate 
there is resolution of DSBs.  This will be determined as cells age from the embryonic to 
differentiated state. This method displays changes in repair rates by tracking the resolution 
of DSBs, however the proteins are surrogate markers of the break and are not definitive in 
displaying restoration of the break.     
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 Materials and Methods  
 
Antibodies and reagents 
 
Primary antibodies used for staining were anti-γ-H2AX (S139) (Millipore, MA), 
anti-p-(S1981)-ATM (Cell Signaling, Beverly, MA), anti-RAD51 (EMD Biosciences), 
anti-53BP1 (BD Transduction Laboratories). 
 
IRIF assay 
 
Performed as described in Chapter 1. Foci were quantified by manual counting and 
the Cell Profiler Software (www.cellprofiler.org). Irradiations were performed using an 
MDS Nordion Gammacell 40 (ON, Canada) research irradiator with a Cs-137 source 
delivering a dose of 1.05 Gy/min. 
 
Cell Cycle Analysis  
 
DNA content was determined by propidium iodide (PI) staining.  Cells were 
trypsinized and fixed with 70% ethanol for 24 h at 4oC. Cells were resuspended in PI stain, 
4mM Sodium Citrate, 5 μg/mL PI, 0.1% Triton-X-100 and RNase A.  Cells were analyzed 
on a Coulter Epics XL MCL flow cytometer at the Massey Cancer Center Flow Cytometer 
Facility.   
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Flow Cytometry 
 
γ-H2AX flow cytometry was performed on cells fixed in 70% ethanol overnight at 
4 oC prior to staining.  Cells were resuspended in 1% FBS/PBS and incubated with anti-γ-
H2AX (1:1000) for 1 hr in PBS 0.1% triton-X, washed, and exposed to anti-mouse Alexa 
488 antibody (1:1000).  After washing the cells were put in PI stain (5 µg/mL in 0.1% 
Triton-X/PBS) and passed through a 50μM nylon mesh filter.  Gating functions were used 
and applied to a 2-D plot of side scatter versus forward scatter to analyze live cells.  γ-
H2AX+ cells were determined by gating a 2D plot of green fluorescence (γ-H2AX) versus 
red fluorescence (PI).  Data were analyzed using EXPO32 ADC softwareTM (Beckman 
Coulter).   
  
Western blotting 
 
Protein lysates were prepared by scraping cells and pelleting of cells in PBS before 
addition of Laemmli lysis buffer (BioRad). Lysates were sonicated for 30 sec and boiled 
for 10 min. Proteins were separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE).  Cells were separated with a 4% stacking gel and then a 
resolving gel based on molecular weight of the protein.  Proteins <150 kDa were resolved 
at 10% acrylamide while proteins >150 kDa were resolved at 5% acrylamide.  Gels were 
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 run at 110V at room temperature and transferred to polyvinylidene difluoride (PVDF) for 
10% gels or nitrocellulose membranes for 5% gels.  10% gels were transferred in Tris-
Glycine buffer at 0.6 amps (A) for 2 h, while 5% gels were transferred at 0.1 A overnight. 
Membranes were blocked in casein for 30 min and exposed to antibodies at 1:200-2000 
dilutions.  Membranes were washed in PBS/0.1% Tween 20.  Specific protein bands were 
detected and quantified using infrared emitting-conjugated secondary antibodies; anti-
rabbit IRDYE 800 (Rockland Immunochemicals, Gilbertsville PA) or anti-mouse Alexa 
680 (Invitrogen) using the Odyssey infrared imaging system from Li-Cor Biosciences 
(Lincoln, NE). Densitometry of immunoreactive band was performed using the Odyssey 
Application Software version 1.2 from Li-Cor Biosciences (Lincoln, NE). 
 
Statistics 
 
Unpaired two tailed t-tests were performed on triplicate data sets using GraphPad 
Prism 3.0 (GraphPad Software, Inc).  P-values are indicated as * <0.05, **<0.01, 
***<0.001, ns=not significant. 
 
Results  
 
Irradiation dose response kinetics of hESCs 
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 Initial experiments involved addressing the appropriate conditions for 
characterizing DSB repair in hESCs. A dose response curve was generated to show the 
effects of irradiation on hESCs.  Cells were grown in chamber slides and treated with 0.1, 
0.5, 1, 2, 5 Gy.  The number of foci per nuclei was counted and plotted.   Phosphorylation 
of ATM at S1981 is often used as a sensitive surrogate for DSB repair in cancer cells 
(Golding et al. 2007), however, the antibody might recognize other cross-reactive proteins 
with a similar p-(S-T/Q) motif as p-S1981 ATM (Matsuoka et al. 2007). Nevertheless, p-
ATM IRIF appeared in a dose-dependent manner (Figure 3-1A and B), as did γ-H2AX and 
53BP1 IRIF at doses as low as 0.1 Gy (Figure 3-1B), suggesting that at least superficially 
hESCs behave similar to human cancer cells. The radiation dose response of DSBs was 
linear between 0.1 and 2 Gy (Figure 3-1B) and there was also a low background of foci in 
these cells.   
 
γ-H2AX staining occurs through out the cell cycle 
 
In order to establish that γ-H2AX would be a suitable marker for quantification of 
the DSB repair kinetics its activation by irradiation across the cell cycle was analyzed.  The 
drugs and treatments that were used throughout these studies have been shown to have 
effects on the cell cycle since it is intertwined with the DNA damage response. Here 
hESCs were irradiated with 0, 2, 5, or 10 Gy and among treatment groups there was an 
equal increase in γ-H2AX staining across the cell cycle as shown by propridium iodide 
staining (Figure 3-2).   
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Figure 3-1.  Characterization of DSB formation in hESCs. (A)  
Depicted is immunostaining of hESCs after treatment with 0, 0.5, and 
2 Gy and exposed to p-(S1981) ATM antibody 15 min after radiation 
(B) Immunostaining of 53BP1, p-(S1981) ATM, and γ-H2AX foci in 
hESCs after single irradiation doses from 0.1 to 5 Gy. Cells were 
fixed 15 min after radiation and exposed to the indicated antibodies. 
Error bars, SEM for data sets n=30 cells per time point. 
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Figure 3-2. γ-H2AX is consistent throughout the cell cycle. 
Cycling hESCs were treated with 0, 2, 5, and10 Gy and fixed 15 min 
after irradiation.  Staining was determined by FACS analysis. 
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 hESCs lack a G1 checkpoint 
 
Changes in cell cycle checkpoints as hESCs differentiate to NPs were determined 
by PI staining (Table 3-1).  hESCs had a much stronger G2/M checkpoint as compared to 
NPs shown by the proportionally greater amount of cells in the G2/M phase.  Here hESCs 
had a peak of 39% of the cells in G2/M at 6 hr after IR compared to 14% at 18-30% for 
NPs.  hESCs did not display a G1 checkpoint because there was no increase in the 
percentage of cell in the G1 phase of the cell cycle after 2 Gy.  NPs, on the other hand, 
increased the number of cells in G1 phase from 58% to 80% at 6 hrs and therefore display 
a G1 cell cycle checkpoint.   Other have similarly shown that ESCs lack a G1 cell cycle 
checkpoint and in mESCs it is possible to induce a checkpoint by over expression of 
CHK2 (Koledova et al.; Aladjem et al. 1998; Hong and Stambrook 2004; Fluckiger et al. 
2006). 
 
hESCs have delayed γ-H2AX repair kinetics 
 
The populations of hESCs, NPs, and fully differentiated astrocytes were used to 
examine differences in radiation repair kinetics by following the appearance and resolution 
of γ-H2AX (Figure 3-3). hESCs showed a significantly greater number of γ-H2AX foci 15 
min after irradiation. The mean focus size in the hESCs was smaller than that in the NPs or 
astrocytes which correlates with a large proportion of cells in S-phase (data not shown) 
(Suzuki et al. 2006). The NPs and astrocytes shared similar profiles regarding the 
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Gy
0                   56           21            22   
2                   56           21            21
2                   39           22            39
2                   50           15            35
2                   50           22            25
0                   58           20            20
0                   58           16             8
2                   72           15             9
2 80           19             3
2                   75           12           13
2                   75           10           14
0                   83           12             4
G1        S       G2/M
DNA Content, %
Time
0 hr
5 min
6 hr
18 hr
30 hr
30 hr
0 hr
5 min
6 hr
18 hr
30 hr
30 hr
Cells
hESC
NP
Table 3-1. Cell cycle checkpoint status.  hESCs and NPs were 
treated with or without 5 Gy and fixed at the indicated time point.  
Cells were stained with PI and analyzed by FACS analysis. 
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  resolution of γ-H2AX.  hESCs has a significantly higher number of IRIF remaining over 
the 24 h time course.  Altogether, hESCs and their more differentiated counterparts show 
full competence, and differences, in the formation and resolution of γ-H2AX that might 
reflect differences in the quality of DSB repair and cell cycle signaling.                                                              
                                                                                                                                                                               
RAD51 foci formation decreases with differentiation  
 
HRR represents a high-fidelity mechanism of DSB repair. It is believed that the cell 
must be in the S or G2 phase of the cell cycle in order for homologous sister chromatids to 
act as a template for the damaged DNA (Valerie and Povirk 2003). The ability of the cells 
to undergo HRR is uniquely dependent on RAD51, which is involved in  
the search for DNA homology and strand pairing stages of repair (Valerie and Povirk 
2003). Thus, we examined the formation and resolution of RAD51 foci after radiation 
(Figure 3-4A).  hESCs and NPs showed significant increases of cells with RAD51 foci 
seen as early as 30 min after IR. Peak levels of cells with RAD51 foci (>75%) occurred 
after 6 h in hESCs whereas NPs peaked at 12 h (Figure 3-4A). Conversely, astrocytes 
showed very few cells with RAD51 foci (<3%) up to 24 h after radiation suggesting that 
these cells completely lack HRR. The differences observed between the hESCs, NPs and 
astrocytes are likely due to differences in proliferative rates. hESCs have a larger 
proportion of cells in S-phase than do the NPs, whereas the astrocytes are no longer 
proliferating and would thus have no S-phase. The small fraction of cells with RAD51 foci  
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Figure 3-3. Characterization of DSB repair kinetics through 
differentiation. hESCs, NPs and astrocytes were seeded in 
chambered cover slips and 16 h after seeding exposed to 2 Gy.  At 
the indicated times cells were fixed and exposed to anti-γ-H2AX 
antibody. Data are expressed as mean foci per cell on counting 100 
cells per time point. Error bars indicate SEM. Data points, foci per 
nucleus; Error bars, SEM for data sets n = 100.  *p < 0.05: **p < 0.01; 
***p < 0.001  
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 in the astrocyte population probably represents residual NPs or astrocyte progenitors we 
also noted when cell proliferation markers were examined (Figure 2-3). 
 
To determine whether the level of cells having RAD51 foci correlated with RAD51 
expression we carried out a western blot of extracts from hESCs, NPs, and astrocytes using 
anti-RAD51 antibody (Figure 3-4B). These cell populations were grown on dishes with 
decellularized MEFs to avoid any protein contamination from the MEFs. The predicted  
molecular mass of human RAD51 is 37-kDa. We found that the 37-kDa RAD51 form 
diminished as the hESCs differentiated into NPs and astrocytes (1, 0.5, and 0.1-fold, 
respectively) correlating well with the RAD51 foci results in Figure 3-4A. In addition, the 
western blot analysis revealed that RAD51 might exist in different forms in the three  
populations. A larger band at 41 kDa than the monomeric 37-kDa form appeared in the 
extract from hESCs, and a band of smaller mass at 31 kDa was evident in the extract from 
the astrocytes. Combined, these data show the reliance of hESCs and NPs on HRR while 
terminally differentiated astrocytes lack functional RAD51 and HRR. 
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Figure 3-4. Differentiation affects RAD51 foci formation and 
expression. (A) Graphical depiction of the percentage of RAD51 foci 
in hESCs, NPs, and astrocytes after 2 Gy. Cells were scored either 
as positive (>1 focus) or negative (≤1 foci) for RAD51. Errors bars, 
SEM for three independent data sets with n > 200. There were 
statistically significant (p < 0.05) increases in the number of cells with 
RAD51 foci after radiation compared to unirradiated cells at all time 
points for hESCs and NPs whereas there was no statistical change in 
the astrocytes. (B) Western blot showing expression of RAD51 in 
hESC, NPs and astrocytes. Fold depicts relative differences in 
RAD51 levels of the 37-kDa form after normalization to β-actin which 
served as a loading control. 
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 Discussion  
 
Here we have established conditions that allow for a low background of IRIF and 
demonstrated a linear response for detection of the DSBs in hESCs form 0 to 2 Gy. Initial 
formation of γ-H2AX foci at early time points varied for the different cell stages.  hESCs 
formed a greater number of foci compared to NPs and astrocytes at 15 minutes. When the 
quantitative and qualitative aspects of cycling normal human fibroblasts were analyzed it 
was found that S phase cells had a greater number of foci that were of smaller mean size 
shortly after radiation (Suzuki et al. 2006). The greater number of foci found in S-phase 
may be due to collapse of the replication machinery at sites of single-strand breaks. This 
parallels the fact that hESCs are cycling very rapidly.  hESCs also retained a larger number 
of foci at later time points which may be due to several factors. One possible reason for the 
delay in resolution could be greater reliance on HRR which is considerably more complex 
and slower process than NHEJ. Another possibility may be more robust cell cycle 
checkpoints in the hESCs. It has been shown resolution of γ-H2AX foci may not only be 
related to the resolution of the DSB, but be necessary for exit from the DNA damage 
checkpoint (Keogh et al. 2006). Current understanding of hESCs is that they have a 
reduced G1 phase and may lack the G1/S DNA damage checkpoint entirely (Becker et al. 
2006). In glioma cells it was found that those cells lacking p53 and hence the G1 
checkpoint response had delayed resolution of γ-H2AX at later time points, which parallels 
this data (Short et al. 2007). This delayed resolution of γ-H2AX is because the phosphate is 
removed by specific phosphatases regulated by the cell cycle. One report shows when cell 
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 cycle checkpoints are over and these phosphatases are activated in order for the cells to 
begin the cell cycle again (Chowdhury et al. 2005).   
 
Our data are consistent with previous reports suggesting that hESCs have a robust 
and active G2/M checkpoint and an absent G1 checkpoint, which first appears in the NPs 
(Hong and Stambrook 2004; Becker et al. 2006; Fluckiger et al. 2006).  Absence of G1 
may be important because it possibly protects the genome of the ESCs.  It may maintain a 
pristine cell population by allowing for increased chance of apoptosis in cells with any 
slight damage.  Also the S/G2 phases of the cell cycle may up regulate expression of 
factors involved in high fidelity repair.  
 
The increase in the number of γ-H2AX foci in the hESCs at later time points after 
radiation may also be due to increased radiosensitivity and cells undergoing apoptosis. 
Apoptosis and DNA fragmentation leads to formation of γ-H2AX foci however this 
activation is global throughout the nucleus and omitted by the cell profiler software 
making it easy to distinguish between apoptosis and residual or potentially repairable 
DSBs at later time points (Rogakou et al. 2000).  It is important to examine γ-H2AX 
staining across the cell cycle since genetic manipulation of the DNA repair enzymes or 
pharmacological inhibition alters the cell cycle checkpoints.  Initial experiments (Figure 3-
2) demonstrate that even with perturbations of the cell cycle γ-H2AX would accurately 
measure DSB repair signaling.  
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 Our results support the idea that, as expected but not yet unequivocally 
demonstrated and reported in the literature, HRR is highly active in hESCs and declines as 
cells differentiate into NPs and disappears entirely in astrocytes. We document that both 
hESCs and NPs rely heavily on HRR by the presence of RAD51 foci formation. hESCs 
display a higher percentage of cells with RAD51 foci at earlier time points then the NPs 
indicating more robust HRR in hESCs than in NPs. The data here demonstrates that cells 
early in development rely to a large extent on HRR and/or high-fidelity DSB repair.  
 
On the other hand, after terminal differentiation of hESCs into astrocytes HRR is 
no longer utilized.  In conjunction with this result, we found that RAD51 decreases in 
expression from the embryonic to the NP state. Furthermore, this protein seems to undergo 
extensive post-translational processing after terminal differentiation to astrocytes.  One 
report showed that cleavage of RAD51 occurred in cells undergoing DNA fragmentation 
and apoptosis (Flygare et al. 1998; Huang et al. 1999). This post-translational processing 
might represent another layer of control for the cell to determine which form of DSB repair 
to utilize.  Investigation of what controls these repair mechanisms must be evaluated 
further in order to conclude how cells maintain the genetic code.  
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Chapter 4 ATM and ATR’s Role in DSB Repair Signaling through 
Differentiation   
 
 
 
 
Introduction  
 
Chapter 3 describes multiple differences in repair mechanisms that were observed 
for embryonic and differentiated cells including the kinetics of repair and types of repair 
utilized as well as changes in the cell cycle.  Earlier it was noted that the G1/S checkpoint 
is absent in hESCs.  A main contributor to the G1/S checkpoint is ATM which may be 
uniquely controlled in these cells.   One study has shown that a possible reason for this is 
that CHK2 is retained at the centrosome after IR exposure in mESCs throughout the cell 
cycle.  In somatic cells, CHK2 is predominantly diffuse within the nucleus and able to 
phosphorylate some of its substrates, including p53, leading to G1/S arrest. Here, a G1/S 
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 arrest can be restored by ectopic expression of CHK2 and the restoration of a G1/S arrest 
protects cells from apoptosis (Hong and Stambrook 2004).  Conflicting reports on the 
localization of p53 have been described in mESCs as well.  One report indicated that DNA 
damage does not activate p53 and these cells undergo p53 independent apoptosis (Chen 
and Wang 1982).  However, others have shown DNA damage in mESCs and hESCs can 
induce differentiation (Lin et al. 2005; Qin et al. 2007).  Further exploration as to what 
controls the DDR can be achieved by inhibiting main components of the signaling 
pathway.  
 
Due to the radiosensitivity of A-T cells and DNA-PK deficient cells there has been 
great effort to develop specific inhibitors against these enzymes due to their potential as 
oncologic therapeutics.   KuDOS Pharmaceuticals has developed KU-55933 (ATMi) and 
KU-57788 (DNA-PKi) against ATM and DNA-PKcs kinases, respectively (Hickson et al. 
2004; Hardcastle et al. 2005).  Both ATMi and DNA-PKi are small-molecule inhibitors 
that compete at the ATP binding site on their respective kinases.  Our laboratory has 
previously shown that ATMi blocks homologous recombination repair in cycling and 
arrested glioma cancer cells (Golding et al. 2007).    
 
Another mechanism to perturb the DNA damage pathways is to use the 
radiosensitizing agent caffeine. Caffeine has been shown to inhibit both ATM and ATR, 
showing a greater specificity for ATM than ATR (Sarkaria et al. 1999).  Therefore 
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 increasing concentration of caffeine should eventually inhibit two of the main signaling 
kinases in this pathway and could provide insight into the components of DSB repair.   
 
Small interfering RNAs represent another method to achieve a decrease in 
expression of genes.  This evolutionary conserved mechanism that provides for viral 
defense and control of development allows for down regulation of proteins or mRNA 
degradation when there is a ≈21-25 nucleotide double stranded RNA with an antisense 
strand complimentary to a particular gene.  When double stranded RNA (dsRNA) from a 
virus or laboratory manipulations is present in the nucleus it will be loaded into the RNA 
induced silencing complex.  Within this complex there is an aptly named RNase enzyme, 
DICER, which cleaves the mRNA that the antisense RNAi strand pairs with endogenously, 
thereby eliminating the mRNA needed to translate the gene of interest. 
  
Materials and Methods 
 
Antibodies and reagents 
 
Primary antibodies used for staining were anti-γ-H2AX (S139) (Millipore, MA), 
anti-p-(T68)-CHK2 (Cell Signaling, Beverly, MA), anti-RAD51 (EMD Biosciences), anti-
53BP1 (BD Transduction Laboratories), anti-β-actin (Santa Cruz Biotechnology). Drugs 
were dissolved in DMSO. Caffeine from Sigma/Aldrich (St Louis, MO) was dissolved in 
water. 
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Downregulation of target genes 
 
Expression of ATR was downregulated using siRNA from Dharamacon, Int. 
(Lafeyette, CO). siRNAs were transfected 24 h after seeding of hESCs at a concentration 
of 80 nM using Dharamafect 1, according to the manufacturer’s instructions.  Efficiency of 
knockdown was analyzed by quantitative polymerase chain reaction (qPCR) and western 
blot.  Downregulation was also performed through Amaxa nuclefection (Lonza) according 
to manufacturer’s instructions.  For ATR knockdown Dharmacon Products L003202-00-
0005 with sequences 5’ GAGAAAGGAUUGUAGACUA 3’, 5’ 
GCAACUCGCCUAACAGAUA 3’, 5’ CCACGAAUGUUAACUCUAU 3’, 5’ 
CCGCUAAUCUUCUAACAUU 3’ were used and for GFP knockdown Dharmacon 
generated 5’ GAACGGCAUCAAGGUGAACdTdT3’ oligo was used. 
 
mRNA analysis  
 
Genomic DNA was extracted using the High-Pure PCR Template Preparation Kit 
(Roche). Amplification of genomic DNA was performed on an ABI 7900HT Real-time 
qPCR instrument using Taqman Gene Expression Master Mix (Applied Biosystems). 
Relative ATR levels were determined after normalizing to GAPDH. The PCR primers used 
for ATR were HS00169878_m1 and for GAPDH were HS99999905_m1 (Applied 
Biosystems). 
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 Results  
 
ATM is dispensable for the formation and resolution of DSBs in hESCs but 
indispensable in astrocytes.   
 
ATM regulates the DNA damage response after IR (Valerie and Povirk 2003). 
ATM has previously been shown to be critical for both HRR and NHEJ  (Riballo et al. 
2004; Wang et al. 2004; Golding et al. 2007). To determine whether ATM plays a role in 
the resolution of IRIF in these cells, we took advantage of a highly specific inhibitor, KU-
55933, of the ATM kinase (Golding et al. 2007). The ability of hESCs, NPs, and astrocytes 
to form and resolve DSBs was assessed by treating cells with ATMi (Hickson et al. 2004). 
After treatment of hESCs with ATMi, there was no statistical difference in the resolution 
of γ-H2AX foci between untreated and ATMi treated cells indicating that ATM is 
dispensable for DSB repair in hESCs (Figure 4-1A). On the other hand, both NPs and 
astrocytes reacted as expected based on our previous results with human glioma cells 
(Golding et al. 2007), i.e., the γ-H2AX foci did not form at all in sharp contrast to the result 
with the hESCs (Figure 4-1A).  
 
To determine whether ATMi inhibited foci formation or promoted the disassembly 
of IRIF, we allowed foci to form and 15 min after radiation ATMi was added to the 
medium (Figure 4-1B). We found that not only did foci formation not occur in astrocytes  
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Figure 4-1.  ATM kinase is important for γ-H2AX foci resolution in 
astrocytes but not in hESCs.  Graphical depiction (left panel) and 
images (right panel) of γ-H2AX foci in hESCs, NPs, and astrocytes 
exposed to 10 μM ATMi (A) 1 h prior to or (B) 15 min after radiation 
with 2 Gy. Asterisks indicate statistical significance between the data 
sets generated with NPs and astrocytes, respectively, with ATMi 
present or not at the same time point.  Data points, foci per nucleus; 
Error bars, SEM for data sets n = 50. 
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 treated with ATMi but the drug even promoted the disassembly of already formed IRIF. 
Over time, the sharp IRIF seen at earlier time points (<3 hrs) became more diffuse and 
completely dissolved over time. Thus, the apparent disappearance of γ-H2AX IRIF to 
levels lower than those seen without ATMi is likely due to the disassembly of foci and not 
more proficient repair as suggested by the steeper slope of the curve for ATMi-treated 
astrocytes (Figure 4-1B). The finding that there was no effect of the ATMi on DSB repair 
in BG01V cells was confirmed with the H9 human embryonic stem cells suggesting that 
this finding was not just an anomaly associated with the BG01V cells (Figure 4-2). 
 
Possible explanations for the lack of an effect of ATMi on the resolution of 
radiation-induced γ-H2AX foci in hESCs include that these cells were refractory to the 
drug (poor uptake, more effective drug break-down, etc) or, alternatively, they do not 
depend on ATM for DSB repair. To distinguish between these two possibilities, we 
examined the effect of ATMi on preventing the phosphorylation of CHK2 at T68 in 
irradiated hESCs. CHK2 phosphorylation at this position is believed to be ATM-dependent 
(Hickson et al. 2004; Golding et al. 2009a). Surprisingly, we found that when ATMi was 
used at a dose that blocks radiation-induced phosphorylation of p53 (S15), H2AX (S139),  
and CHK2 (T68) in an ATM-dependent manner in human tumor cell lines (Golding et al. 
2009b), it did in fact inhibit CHK2 phosphorylation >85% in irradiated hESCs (Figure 4-
3). Similarly, γ-H2AX levels were reduced ~50% when cells were exposed to ATMi. 
Therefore, the lack of an effect of ATMi in hESCs by IRIF assay is not because the drug  
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Figure 4-2. DSB repair in H9 hESCs is unaffected by treatment 
with ATMi and DNA-PKi.  Graphical depiction of γ-H2AX foci in 
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Figure 4-3.  ATM kinase is functioning in hESCs. Extracts from 
hESCs 15 min after exposure to 5 Gy with or without ATMi (10 µM) 
added 1 h prior to radiation. Fold change depicts phosphorylation of 
CHK2 (T68) and H2AX (S139). β-actin served as loading control. 
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 does not work or that the ATM kinase is not available or inactive in these cells, but instead 
because ATM is not critical for the formation and resolution of repair foci in hESCs.  
 
Recent reports have indicated that the CHK2 pathway is compromised in mESCs 
and this protein is retained at the centrosome, unable to translocate to the nucleus (Hong 
and Stambrook 2004).  This phenomenon was examined in hESCs to see if CHK2 was 
sequestered in a similar manner as the mESCs.  When examined if this were true in ESCs, 
it was found that pCHK2-threonine 68 was located at the mitotic spindle in hESCs (Figure 
4-4). This can be demonstrated by colocalization of CHK2 with γ-Tubulin, a protein 
present in large quantities at the mitotic spindle.     
 
Inhibiting ATR abrogates DSB repair in hESCs.   
 
ATR is known to serve as backup for ATM, is critical for regulating the DDR 
during replication, and is important for DSB repair (Cliby et al. 1998; Wang et al. 2004). 
Caffeine inhibits both ATM and ATR, with a greater potency against ATM than ATR 
(Sarkaria et al. 1999). Thus, caffeine was first used to examine the effects on γ-H2AX foci 
formation after irradiation. At 2 mM, caffeine is expected to inhibit ATM but not ATR 
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Figure 4-4. pCHK2 is localized to the centrosome. hESCs were 
prepared for confocal microscopy and then incubated with pCHK2 
(green) and γ-tubulin (red). Arrows show colocalization of proteins. 
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 (Golding et al. 2004). Indeed, at this concentration there was no effect on γ-H2AX foci 
formation (Figure 4-5A), a result which is in agreement with the finding that ATMi does 
not affect foci formation in these cells (Figure 4-1).  However, after treatment with 4 and 8 
mM, a 21% and 47% reduction in γ-H2AX foci, respectively, was observed at early times 
after irradiation (Figure 4-5A, top panel). Similar levels of inhibition were seen at 1 h as 
well.   
 
Furthermore, RAD51 foci were almost completely absent (≤3 h) in cells treated 
with 8 mM caffeine and reduced with 4 mM (Figure 4-5A, bottom panel). Later time 
points (>3 h) showed significant cell death after treatment with 4 and 8 mM caffeine and 
were therefore not pursued further. Combined these results suggest that ATR and not ATM 
is critical for DSB repair in hESCs. Because hESCs depend on HRR to a large extent, it is 
likely that ATR regulates HRR in hESCs as has been shown in fibroblasts (Wang et al. 
2004). 
 
To confirm the result with caffeine and more clearly establish a role for ATR in 
DSB repair in hESCs, we transfected the cells with siRNA targeting ATR and examined 
the impact on DSB repair.  hESCs transfected with ATR siRNAs showed significant (45-
70%) knockdown of ATR expression, but no effect on DNA-PKcs levels (Figure 4-5B 
and C). This knockdown led to a reduction of γ-H2AX foci by >70% in cells treated with 
radiation (Figure 4-5D and E). Interestingly, unirradiated cells showed low levels of γ-
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 H2AX foci, which increased almost 2-fold when ATR was knocked down. These results 
suggest that ATR is critical for HRR in hESCs. 
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bars, SEM for data sets n = 50. B. Graphical depiction of ATR mRNA 
levels normalized to GAPDH mRNA after transfection with GFP 
control siRNAs and siRNAs targeting ATR. Experiments were 
performed in triplicate, and the SEM indicated by error bars. C. 
Western blot showing ATR expression 48 h after transfection of 
BGO1V cells with GFP control siRNAs or siRNAs targeting ATR.  The 
fold change in ATR was calculated after normalization to DNA-PKcs 
which served as a loading control.  D. Graphical depiction of the 
effects of ATR knockdown on DSB repair determined by γ-H2AX foci. 
Cells were transfected with GFP control siRNAs or siRNAs targeting 
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Data points, γ-H2AX foci per nucleus; Error bars, SEM for data sets n 
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DAPI staining showing nuclei (blue). 
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 Discussion 
 
Experiments described in this chapter delineate changes in DSB repair through 
differentiation.  An unexpected finding herein was that ATMi blocked the formation of γ-
H2AX and p-(S1981) ATM foci in NPs and astrocytes, but had no effect on the repair in 
hESCs. ATMi functions in hESCs since radiation-induced CHK2 phosphorylation was 
inhibited at an ATM-specific phosphorylation site. There was also a significant increase in 
the γ-H2AX foci in the unirradiated cells with ATR knockdown. This result has been 
shown before in ATR deficient mouse embryonic cells due to replicative stress induction 
as a result of ATR not signaling for repair (Murga et al. 2009).  Our data suggest that 
astrocytes and NPs rely to a large extent on ATM for the formation and maintenance of 
repair complexes, whereas hESCs (and NPs to a lesser extent) may have ATR acting as a 
mediator to identify DSBs. ATR is an essential protein, whereas ATM is not, suggesting 
that ATR has a vital role early in development as suggested by the inability to obtain ATR 
knockout mice (Brown and Baltimore 2000). In conditional knockouts, ATR has been 
shown to be critical for preservation of the stem cell compartment of adult tissues 
(Ruzankina et al. 2007).  ATR may be directly responsible for DSB signaling in hESCs, 
and to some extent in NPs, similar to tumor cells. Previous reports established that ATM is 
inhibited by caffeine more readily than ATR (Sarkaria et al. 1999; Golding et al. 2004). 
We show that caffeine at higher doses of >4 mM inhibit IRIF formation. In support of this 
finding, siRNA-mediated knock down of ATR and subsequent reduction in γ-H2AX foci 
strongly supports the notion that ATR is absolutely critical for HRR in hESCs.  We have 
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 also shown that CHK2 phosphorylation is lost in presence of ATMi and this protein may 
be sequestered at the centrosome similar to what is found in mESCs.  Therefore this 
pathway is active in the early signaling events of the checkpoint and the ATM kinase 
inhibitor is effective at decreasing its function on known substrates involved in the G1 
checkpoint. 
 
We conclude that the lack of an effect of ATMi in hESCs is not because the drug 
does not work or that the ATM kinase is not available or active in these cells, but instead 
because ATM is not critical for the formation and resolution of DSBs in hESCs. We show 
that KU-55933 is effective in hESCs at lower concentrations typically used to block the 
DDR in tumor cell lines since radiation-induced CHK2 and H2AX phosphorylation was 
inhibited (Golding et al. 2009b). This consistent effect of KU-55933 on hESC would 
thwart the notion of any significant effect of a drug pump (Momcilovic et al. 2009b). The 
reason why we do not see any effect of KU-55933 on the formation of p-(S1981)-ATM 
foci after radiation of hESCs is most likely because this antibody recognizes a number of 
other DDR proteins phosphorylated by ATM and ATR, such as SMC1, in addition to auto-
phosphorylated ATM (Matsuoka et al. 2007). 
 
Recent publications have shown that checkpoint signaling in irradiated hESCs was 
not affected by ATMi.  Effects in this publication were seen only at levels 10 fold higher 
than in other cell lines (Momcilovic et al. 2009a).  Such high concentrations may indicate 
that the drug is having off target effects.  In parallel to the publication of these findings it 
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 was found that ATM was not involved in the maintenance of genetic stability in hESCs 
when this gene was removed by targeted allele disruption (Song et al.).  Importantly we 
show ATR is responsible for the formation and resolution of DNA DSBs in hESCs and 
likely HRR signaling.  
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Chapter 5  NHEJ in hESCs 
  
 
 
 
Introduction 
 
Chapters 3 and 4 began to unravel unique properties of ESCs including their 
reaction to DSBs.  While hESCs seem to rely on HRR extensively, there is no clear 
documentation that they utilize NHEJ.  Since NHEJ dominates in G1 and hESCs have an 
abrogated G1 checkpoint, NHEJ may be deficient in these cells.  There are reasons 
deficient NHEJ could be advantageous to maintain hESCs genomic stability.  One reason 
is that unrepaired damage that has occurred in G1 may lead to increased apoptotic 
signaling, which has been shown to be upregulated in ESCs.  This mechanism would clear 
damaged cells from the gene pool.   Deficient NHEJ would also increase the level of HRR 
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 since the factors of each mechanism are in competition at site of the DSB (Allen et al. 
2002).  This would increase genomic stability by allowing greater use of the mechanism 
with the highest fidelity of repair.  The details of this process are described earlier (Figure 
1-4).  
 
In NHEJ evidence shows small sequence gaps with microhomology are filled by 
Pol µ and Pol λ (Lee et al. 2004; Nick McElhinny et al. 2005).  Several factors determine 
whether HRR or NHEJ is employed including stage of the cell cycle, growth factor 
signaling, and the severity and type of damage (Valerie and Povirk 2003; Golding et al. 
2009a). Recently, it has been shown that in S. cerevesiae the extent of DNA resection after 
damage can influence the choice of which mechanism of DSB repair is utilized as well 
(Huertas et al. 2008).    
 
Materials and Methods 
 
Antibodies and reagents 
 
Primary antibodies used for staining were anti-DsRed,  anti-β-actin, anti-Oct3/4 
from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-HA from Cell Signaling 
(Beverly, MA). 
 
NHEJ repair.   
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BG01V/NHEJ-red cells were isolated by infection of BG01V cells with a lentivirus 
(WPXLd-2xISceI-DsRed) harboring a repair cassette (hereafter referred to as the NHEJ-
red) (Figure 5-1A) positioned upstream of the DsRed reporter gene that was recently 
described with the exception that an IRES-NEO selection cassette was added (Figure 5-
1A) (see Supplemental Methods in (Golding et al. 2009a)). Cells resistant to G418 were 
cloned by dilution and screened for the integration of NHEJ-red  by infection with 
adenovirus expressing the I-SceI endonuclease from Saccharomyces cerevisiae (Ad-SceI) 
(Golding et al. 2009a), followed by subsequent analysis of DsRed expression.  Cells were 
infected with adenovirus with a multiplicity of infection (MOI) of 30 while dishes were 
rocking at 37oC for 4 h. 
 
The NHEJ-red assay has been described previously (Golding et al. 2009a), and 
relies on a cassette containing two I-SceI recognition sequences flanking an ATG codon 
that when not cut by I-SceI, acts as a decoy initiation codon, preventing translation of the 
DsRed reporter gene. Upon cleavage with I-SceI at both recognition sequences, the decoy 
codon is excised within a 25-base sequence stuffer fragment.  If NHEJ DNA repair occurs,  
the DNA is sealed, and DsRed expressed from a downstream, previously out of frame 
ATG codon (see Figure 5-1A).  The two I-SceI recognition sites are in opposite 
orientations, such that when both are cleaved with I-SceI and the stuffer fragement of the 
vector is excised, two partially complementary 5′ overhangs are generated: TTAT and 
TATT.  If the generated partially complementary ends anneal without DNA-end resection, 
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 a two-base gap will result on both strands which would be filled in, likely by a gap-filling 
polymerase.  This possible repair scenario would result in a repair joint sequence reading 
TTATAA, which we define as high-fidelity NHEJ (“HiFi” NHEJ).  More extensive 
resection would still result in DsRed expression unless the deletion is so extensive that it 
removes the downstream DsRed ATG codon or removes the upstream promoter.  NHEJ 
events are then determined by FACS of DsRed positive cells and/or genomic qPCR, or by 
cloning and DNA sequencing. 
    
 
DsRed 2x-SceI-NHEJ cassette Cell Cloning 
 
After infection with DsRed cassette, hESCs were selected for integration of the 
virus 48 hrs after infection.  Cells were selected for integration of the cassette with 
100µg/mL of G418. After one week cells were trypsinized and plated in 24 well plates 
containing decellularized matrix.  Single colonies were then picked after cells had grown 
up and these cells were tested for formation of the 125 base pair product amplicon relative 
to β-actin.  Several positive clones were then grown up and a clone designated 4 was used 
for experimentation.  
 
Genomic DNA was extracted using the High Pure PCR Template Preparation Kit 
(Roche).  Amplification of genomic DNA was performed on an ABI 7900HT Real-time 
qPCR instrument using SYBR Green (ABI, Foster City, CA). Relative NHEJ levels were 
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 determined after normalizing to β-actin levels. The PCR primers used for the NHEJ 
quanitifcation were 5′-CACGAGACTAGCCTCGAGGTTT, 3′-
CTTGAAGCGCATGAACTCCTT, and for β-actin were 5′-
TCACCCACACTGTGCCCATCTACGA, and  
3′-CAGCGGAACCGCTCATTGCCAATGG (synthesized by the VCU Massey Cancer 
Center Nucleic Acids Research Facility).  Analysis was performed with the ABI Relative 
Quantification Assay with the cycling conditions as follows; Cycle 1 for 1 cycle at 95oC 
for 10 min, Cycle 2 for 40 cycles of 95oC for 15 sec followed by 60oC for 1 min.  Relative 
DNA levels of the NHEJ repair product and β-actin with Sequence Detection Systems 
software.   
 
 In addition to quantitative SYBR Green PCR, bands were also separated on a 9% 
non-denaturing polyacrylamide gel, detected by ethidium bromide staining, and imaged on 
a Typhoon 9410 variable mode scanner (General Electric Healthcare). 
 
DsRed Analysis 
 
DsRed fluorescence was detected with flow cytomtery, performed on live cells.  Briefly, 
cells were trypsinized and taken up in DMEM/10% FBS.  Gating functions were applied to 
a 2-D plot of side scatter versus forward scatter so the live cell population could be 
analyzed.  DsRed+ cells were quantified by gating a 2D plot of green fluorescence versus 
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 red fluorescence. Cells were analyzed on a Coulter Epics XL MCL flow cytometer at the 
Massey Cancer Center Flow Cytometer Facility.   
 
Results 
 
hESCs utilize NHEJ for DSB repair.    
  
Previous work has shown that hESCs are highly proliferative cells with strong G2 
checkpoints and an absent G1 checkpoint (Momcilovic et al. 2009a).  For this reason it is 
believed hESCs would depend extensively on HRR.  Indeed, we recently showed that 
hESCs form RAD51 foci, a marker for HRR, far more extensively and express RAD51 at 
10-fold higher levels than differentiated astrocytes (Adams et al.).  We also demonstrated 
that the relatively fast repair kinetics using γ-H2AX as surrogate marker suggested that 
hESCs have NHEJ (Adams et al.). However, both γ-H2AX and 53BP1 foci resolution was 
relatively unresponsive to a small molecule inhibitor of DNA-PKcs kinase suggesting that 
NHEJ in hESCs is largely independent of DNA-PKcs (Adams et al.). To determine the 
nature of NHEJ in hESCs, and to clarify the role of DNA-PKcs in NHEJ these cells, we 
engineered the hESCs with a lentivirus carrying a repair cassette that would make them 
more amendable for repair analysis.  
 
BG01V cells were infected with the NHEJ-red lentivirus (LV) (Figure 5-1A) 
followed by cell cloning and expansion in G418 supplemented media.   A number of 
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 clones were isolated and one was chosen for further study.  The hESC clone was infected 
with the I-SceI expressing adenovirus and shown to be positive for Oct3/4 nuclear staining, 
indicating that they are hESCs and positive for DsRed after infection with Ad-SceI. 
Therefore, the hESCs appear to utilize NHEJ since the production of DsRed after I-SceI 
adenoviral infection could only occur by repair with NHEJ (Figure 5-1B). 
 
Repair of NHEJ-DsRed cassette detected by novel qPCR assay  
 
After validation of the fluorescence-based NHEJ assay via immunocytochemistry, 
the NHEJ cassette integrated in to the genome was used as the basis for a more rapid qPCR 
assay.  Determining the levels of NHEJ in this assay relies on the 2X-SceI-NHEJ vector, 
primer design, and qPCR conditions.  The vector is cleaved by SceI at two sites and 
resealed with loss of a 25 bp fragment.  Primers amplify the DNA with greater efficiency 
than the uncut vector starting material.  Determining DNA break resealing via qPCR is a 
more direct, quantitative method that eliminates transcriptional or translational effects that  
may compromise fluorescent protein based DNA repair assays (18). Figure 5-2A shows a 
time course for the increase of the 125 bp band produced by NHEJ.  The PCR band is  
shown by gel electrophoresis to be the size of the product after loss of the small DNA 
fragment and repair by NHEJ (Figure 5-2B). The relative change in fluorescence detected 
in the infected samples while using the same PCR primer set shows the 125 base product is  
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1                    10                    20                   30                     40                       50 60                     70                       80
GGATCCATTACCCTGTTATCCCTACTCGAGCCATGGCTAGGGATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCC
CCTAGGTAATGGGACAATAGGGATGAGCTCGGTACCGATCCCTATTGTCCCATTAGGGCCCATGGCCAGCGGTGGTACCGG
CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCC
TATTGTCCCATTAGGGCCCATGGCCAGCGGTGGTACCGG
NHEJ
GGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCC
CCTAGGTAATGGGACAATATTGTCCCATTAGGGCCCATGGCCAGCGGTGGTACCGG DsRed+ cells
Removes ATG decoy
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DNA pol fill-in (-AA-) 
= “high fidelity”
NHEJ
Repair Site 
Alteration?
PCR Cloning Sequencing
PsiI Band Analysis
5’ TAGGGATAACAGGGTAAT 3’
3’ ATCCCTATTGTCCCATTA 5’
A
DAPI DsRed
Oct4 Merge
B
Figure 5-1. NHEJ-red repair cassette and processing of I-SceI 
cut. (A) Schematic of the NHEJ-red cassette. (B) Oct3/4 (green) 
positive hESCs display DsRed (red) positive cells 48 hrs after 
infection with 30 multiplicity of infection (MOI) of Ad-SceI adenovirus.  
DAPI shows nuclear staining. 
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Figure 5-2. Repair by NHEJ can be monitored by qPCR.  (A)  
Time course exhibiting an increase in SYBR green fluorescence after 
amplification by qPCR in hESCs. (B) Poly-acrylamide gel showing the 
NHEJ repair product at ~125 base pair fragment at indicated times. 
(C) Relative NHEJ levels after infection with Ad-SceI adenovirus with 
30 MOI at 24 hrs. 
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  detected at levels 139-fold higher than the same uninfected clone (Figure 5-2C).   
 
NHEJ repair kinetics through differentiation 
 
It is possible that a change in adenovirus expression may occur through 
differentiation which would alter the reliability of the repair assay.  Figure 5-3A shows 
that when the hESCs, NPs, and astrocytes are infected with an equal amount of adenovirus 
containing HA-tagged I-SceI there is an identical amount of HA protein expressed at 24 h.  
Since the enzyme is cutting at identical rates we are able to show the quantity of NHEJ 
repair increases through differentiation. Figure 5-3B shows that astrocytes have 2.3 fold 
greater amount of DNA repaired compared to hESCs. As cells transition from hESCs to 
NPs there is a trend of increase in the DNA repaired by NHEJ, however this difference is 
not significant.   This data is supported by flow cytometry analysis analyzing the quantity 
of DsRed.  Here again we showed an increase in DsRed, representing NHEJ repair, as cells 
differentiate.  Due to the time needed for translation of the DsRed protein 48 and 72 h time 
points were utilized.  This assay shows quantitatively the DsRed is produced faster in 
astrocytes and once again there is no difference between hESCs and NPs.  At 48 h the 
astrocytes had 2.6 fold more cells expressing DsRed than hESCs (Figure 5-3C). Also at 72 
h there is a 1.6 fold increase in DsRed in astrocytes (Figure 5-3C and D).  Once again 
there was no significant difference between the hESCs and the NPs. 
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Figure 5-3. NHEJ occurs with faster kinetics after terminal 
differentiation.  (A) An equal number of hESCs, NPs and astrocytes 
were seeded and 12 h later infected Ad-SceI at an MOI of 30.  
Samples were harvested 24 h after infection.  (B) BG01V, NP, and 
astrocyte/NHEJ-red cells were infected with Ad-SceI and collected at 
24 h post-infection. (Columns) Relative NHEJ levels were normalized 
to β-actin; (Error bars) SEM for data sets n = 3. Fold (x) indicates 
changes in the relative repair levels when compared to the hESC 
sample. *p < 0.05: **p < 0.01; ***p < 0.001. (C) BG01V, NP, and 
astrocyte/NHEJ-DsRed cells were infected with Ad-I-SceI at an MOI 
of 30. DsRed events were determined by FACS 48 and 72 hrs after 
infection. Fold (x) indicates changes in the relative repair levels when 
compared to the hESC sample. *p < 0.05: **p < 0.01; ***p< 0.001; ns 
= non significant. (Columns) % DsRed+ cells with 60,000 events 
collected; (Error bars) SEM for data sets n = 3. (D) Representative 
images of DsRed+ cells at 72 hr after infection. 
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   Discussion   
 
The IRIF foci assay utilizes surrogate markers for repair to determine differences in 
ESCs and differentiated progeny, however further proof with a repair cassette is needed to 
further substantiate previous findings.  Herein we employed the use of a modified cassette 
that can not only define the quantity of DNA repaired by NHEJ, but also the fidelity with 
which the DSB was repaired.  There is a requirement for high fidelity DNA repair of DSBs 
in ESCs since they give rise to all the cells of the organism. Knockout studies demonstrate 
ESCs utilize HRR compared to NHEJ as a principal mechanism of repair (Orii et al. 2006). 
These cells are proficient in HRR as indicated by the extensive formation of RAD51 foci 
after irradiation.  Current understanding is that there is correlative evidence that NHEJ may 
exist in hESC but no direct linkage has been shown (Biton et al. 2007; Banuelos et al. 
2008).  There is strong evidence however that in mESCs DNA-PKcs is not expressed and 
NHEJ is defective in these cells (Banuelos et al. 2008). Here we show that Oct3/4+ 
embryonic stem cells in fact utilize NHEJ as a method for DSB repair. 
 
  Also using this NHEJ cassette we were able to demonstrate slower repair kinetics 
in the proliferating hESCs and NPs as compared to the terminally differentiated astrocytes.  
This was shown not only through the PCR assay but also examining DsRed positive cells 
at later times to allow for translation of the protein.  Current understanding of the D-NHEJ 
is that it is defined by faster repair kinetics compared to alternative forms of NHEJ repair.  
The B-NHEJ also seems to occur in the G2 phase of the cell cycle more readily (Wu et al. 
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 2008). It has been shown that cells lacking components of the D-NHEJ perform end 
joining with the preferential use of microhomologies (Kabotyanski et al. 1998). This data 
may indicate the fact that rapidly cycling hESCs may show a preference for B-NHEJ or 
microhomology mediated NHEJ compared to differentiated astrocytes. 
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Chapter 6   High Fidelity Repair in hESCs 
 
 
 
 
Introduction 
Chapter 3 showed that a current small molecule inhibitor targeted against ATM is 
ineffective at altering the recognition or resolution of the DSB in hESCs.   These assays 
follow surrogate markers of repair and are not probing the actual DNA break site.  Using 
the described NHEJ assay it is possible to scrutinize whether the cutting of DNA by a 
restriction enzyme can be altered by the drugs.   It was shown in Chapter 4 that the cycling 
hESCs and NPs have slower repair kinetics.  
 
Interestingly a backup NHEJ pathway utilizing poly (ADP-ribose) polymerase-
1(PARP-1), Histone H1 and Ligase III/XRCC1 has begun to be described (Audebert et al. 
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 2004; Wang et al. 2006).  This new pathway has been studied in fibroblasts and cancer 
cells, but not in hESCs (Bennardo et al. 2008; Iliakis 2009).   Current studies in a chicken 
B cell line show that knockout of D-NHEJ factors slows repair kinetics, but equal amounts 
of repair can occur. Interestingly, additional knockout of HRR factors as well as D-NHEJ 
factors produced the same effect as knocking out D-NHEJ factors alone so this form of 
repair is independent of HRR (Wang et al. 2001).  
 
 It has also been shown that there is a cell cycle dependence on whether DNA-PK 
dependent or alternative forms of NHEJ are used.  When the three dominant NHEJ factors, 
DNA-PKcs, Lig4, and Ku70, are knocked out there is a defect in repair in cells in the G1 
phase but not in the G2 phase (Wu et al. 2008).  These data indicate a cell cycle regulation 
of the backup NHEJ similar to HRR.   Inherent to all of these studies is the use of cancer 
cells or immortalized cells that are not indicative of true physiologic signaling.  The 
current system utilized begins to clarify when B-NHEJ may predominate.  
 
Currently there is contrasting evidence as to which factors may control the fidelity 
of NHEJ.  Some studies suggest that the D-NHEJ prevents loss of genetic information 
(Difilippantonio et al. 2000; Gao et al. 2000), while others show that microhomology 
mediated repair may occur to an equal or greater extent when these factors are absent 
(Kabotyanski et al. 1998; Perrault et al. 2004).  The differentiation assay preformed here 
can show whether cell cycle, differentiation, or epigenetic effects collectively alter the 
usage of this microhomology directed NHEJ repair. 
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Materials and Methods 
 
Antibodies and reagents 
Primary antibody used for staining were anti-γ-H2AX (S139) (Millipore, MA). 
KU-59436 (PARPi) was dissolved in DMSO. 
 
 
Downregulation of DNA-PKcs 
DNA-PKcs and ATR expression was knocked down using the Smartpool M-
005030-01-05 and the SmartPool M-003202-05, respectively. A GFP siRNA (5’-
GAACGGCAUCAAGGUGAACdTdT-3’) was used as a control. All siRNAs were 
purchased from Dharmacon.  hESCs were nucleofected using program A-023 (Lonza 
Nucleofector II) and Nucleofector Embryonic Stem Cell Kit II solution and 200 nM 
siRNAs according to the manufacturer’s recommendations as described previously (Adams 
et al.).  
 
 
“HiFi” DsRed Repair Cassette Analysis 
qPCR was used to determine the extent of NHEJ as described in Chapter 4. When 
amplifying genomic samples to be digested with PsiI, Amplitaq Gold Master mix (ABI, 
Foster City, CA) was used.  The samples were then digested with 5 units of PsiI, in NEB 
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 buffer 4, in 25 uL reactions.  Digested bands were separated on a non-denaturing 
polyacrylamide gel, and stained and imaged as previously described.  Densitometric values 
were quantified using QuantityOne analysis software (Bio-Rad). 
 
 
PCR Product Cloning and Sequencing  
 
Genomic DNA was extracted using the High Pure PCR Template Preparation Kit 
(Roche).  Amplification of genomic DNA was performed on an ABI 7900HT Real-time 
PCR instrument using the Amplitaq Gold Master Mix (ABI, Foster City, CA). Relative 
NHEJ levels were determined after normalizing to β-actin. The PCR primers used were the 
same as described for the qPCR assay. DNA was cloned using the TOPO TA Cloning kit 
(Invitrogen) as described by the manufacturer’s instructions.   DNA sequencing was 
performed by MCV-VCU Nucleic Acids Research Facility.  
 
Results 
 
Astrocytes rely to a large extent on NHEJ.  
To further characterize DSB repair in the astrocytes, we examined a possible 
dependence on DNA-PKcs in the repair of DSBs. Taking advantage of the highly specific 
DNA-PKcs kinase inhibitor, KU-57788 (NU7441) (Hardcastle et al. 2005; Povirk et al. 
2007; Golding et al. 2009b), we show that DNA-PKcs, in part, is important for the 
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 resolution of both γ-H2AX and 53BP1 foci in astrocytes (Figure 6-1A, top panel). At 6 h 
after irradiation, >40% of γ-H2AX foci remained in the DNA-PKi-treated astrocytes 
compared to only 21% in the untreated. Importantly, the DNA-PKi-treated cells had more 
repair foci remaining throughout the entire time course, suggesting that DNA-PKcs is 
important for repair but repair is not fully dependent on DNA-PKcs. This response is in 
sharp contrast to that seen when cells were treated with ATMi where the slope of foci 
disappearance was steeper, most likely reflecting the disassembly of repair complexes (see 
Figure 4-1). Similarly, ~80% of 53BP1 foci remained in the DNA-PKi-treated cells 
compared to only ~30% in the untreated cells when the drug was added after irradiation 
(Figure 6-1A, bottom panel). These results further suggest that repair complexes remain 
at the DSB but repair proceeds slower, reflecting a dependence (50-65%) on DNA-PKcs, 
presumably as a critical component in NHEJ (Valerie and Povirk 2003). Importantly, when 
both DNA-PKi and ATMi were combined, there was a complete lack of γ-H2AX foci 
formation after irradiation, demonstrating an effect similar to ATMi alone (Figure 6-1A).  
 
Whereas hESCs depend predominantly on HRR, as we have shown here, there was 
no effect of DNA-PKi on the resolution of either γ-H2AX or 53BP1 IRIF in hESCs 
(Figure 6-1B), a result which is in sharp contrast to that seen with the astrocytes. This 
result with DNA-PKi was also recapitulated with the H9 hESC line (Figure 4-2) and 
suggests that DNA-PKcs is not important for DSB repair in hESCs.  
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Figure 6-1.  Astrocytes rely completely on NHEJ. (A) Graphical 
depiction of γ-H2AX (top panel) and 53BP1 (bottom panel) foci in 
astrocytes after radiation. Cells were treated or not with ATMi (10 
µM), DNA-PKi (2.5 µM) or both for 1 h followed by irradiation with 2 
Gy. Asterisks designate statistical significance between data sets of 
untreated and drug-treated cells at the same time point. (B) Graphical 
depiction of γ-H2AX (top panel) and 53BP1 (bottom panel) foci in 
hESCs treated or not with DNA-PKi (2.5 µM) followed by radiation 
with 2 Gy. Data points, foci per nucleus; Error bars, SEM for data sets 
n = 50.  
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 ATM and DNA-PKcs kinases are not critical for NHEJ in hESCs.   
It was previously shown that the ATMi, is only partially effective at abrogating 
DSB repair even though checkpoint signaling in hESCs was blocked (Adams et al.; 
Momcilovic et al. 2009b).  In order to verify that ATMi and DNA-PKi small molecule 
inhibitors were entering the cells, analysis of p-KAP1 and γ-H2AX were analyzed. KAP1 
is involved in chromatin remodeling after DNA damage and its activation is dependent on 
ATM and DNA-PKcs at early time points (Tomimatsu et al. 2009).   Furthermore, we 
showed recently that H2AX phosphorylation is completely blocked after irradiation at 
early times (≤15min) when both drugs are applied to glioma cells (Golding et al. 2009b). 
Here, we show that KAP1 and γ-H2AX are reduced to near basal levels after 6 Gy when 
treated with a combination of ATMi and DNA-PKi (Figure 6-2A).    
Since these drugs alter DDR signaling in the hESCs we analyzed the effect on 
NHEJ-red assay and show, in line with previous results, that both ATMi and DNA-PKi 
were relatively ineffective at inhibiting NHEJ repair in hESCs (Figure 6-2B) (Adams et 
al.). However, there was significant inhibition of 40-50% on NHEJ repair in the presence 
of the two drugs in NPs (Figure 6-2C).  This inhibition becomes even more pronounced 
when these cells were further differentiated into astrocytes.  Here, NHEJ was reduced to 
25% when treated with ATMi and 27% when treated with DNA-PKi (Figure 6-2D).  
Altogether, these results suggest that NHEJ in hESCs is not dependent on either ATM or 
DNA-PKcs.  
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Figure 6-2.  Specific DNA-PKcs and ATM kinase inhibitors 
become more effective as cells differentiate.  (A) hESCs were 
harvested 5, 10, and 15 min after exposure to 6 Gy with or without 
ATMi (10 µM) and DNA-PKi (2.5 µM) or both. Drugs were added 15 
min prior to radiation. Fold change depicts phosphorylation of KAP1 
(S824) and H2AX (S139) after normalization to Chk1 which served as 
a loading control.  (B) BG01V/NHEJ-red (C) NP/NHEJ-red and (D) 
astrocyte/NHEJ-red cells were infected with Ad-SceI and then treated 
with either ATMi at 10 μM or DNA-PKi at 2.5 μM, 1 h after infection. 
Cells were collected at 24 hr post-infection. (Columns) Relative NHEJ 
levels was normalized to β-actin; (Error bars) SEM for data sets n = 
3. Fold (x) indicates changes in the relative repair levels when 
compared to the hESC sample.  Differences in the scale of the 
separate cell populations (B-D) are due to variation in the uninfected 
sample PCR amplification from 3 separate experiments. Statistical 
significance is marked between datasets and the SceI expressing 
cells with no drug treatment. 
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 DNA-PKcs knockdown only slightly inhibits NHEJ in hESCs 
 
To further investigate the results with the DNA-PKi and to better understand DNA-
PKcs’ role in NHEJ in hESCs, we transfected the hESCs with siRNA targeting DNA-PKcs 
and then examined the impact on NHEJ.  hESCs transfected with DNA-PKcs siRNAs 
showed significant (90%) knockdown of DNA-PKcs expression between 48 and 72 hrs 
(Figure 6-3A). It was also important to analyze the effect of the knockdown of DNA-PKcs 
on adenoviral expression.  Our lab has noted that changes in chromatin remodeling factor 
expression such as KAP-1 alter adenoviral expression which can bias the repair assay and 
fortunately, the 90% knockdown of DNA-PKcs did not affect the expression of SceI 
(Figure 6- 3B).  Despite the equal adenoviral expression there was a reduction in NHEJ  
repair by 30-35% as determined by both flow cytometry and qPCR repair assay (Figure 6-
3C and D).  Therefore, in hESCs DNA-PKcs appears to play only a minor role in NHEJ. 
 
 
High Fidelity NHEJ decreases as hESCs differentiate 
If hESCs rely on alternative forms of repair it is possible there would be a 
difference in the fidelity to which the repair occurs.  As hESCs differentiated to NPs and 
astrocytes there was a progressive decrease in the extent to which the overhangs were filled 
in with AA nucleotides indicating “HiFi” NHEJ.  hESCs displayed a 2.6-fold higher levels 
of “HiFi” NHEJ compared to astrocytes, whereas NPs displayed a 1.8-fold increase 
compared to astrocytes (Figure 6-4A and B).  A U87 cell clone carrying the NHEJ-red  
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Figure 6-3. DNA-PKcs knockdown partially reduces NHEJ in 
hESCs. (A) DNA-PKcs expression 48 and 72 h after nucleofection of 
BGO1V cells with GFP control siRNAs or siRNAs targeting DNA-
PKcs or ATR.  The fold change in DNA-PKcs was calculated after 
normalization to ATR which served as a loading control.  (B) HA-SceI 
levels in BG01V cells 48 h after infection Ad-SceI infection.  (C) 
BG01V/NHEJ-red cells were infected with Ad-SceI at an MOI of 30 at 
48 h after nucleofection. DsRed events were determined by FACS 48 
h after infection. Fold (x) and statistical significance indicates 
changes in the relative repair levels when compared to the SceI 
expressing siGFP sample. (Columns) % DsRed+ cells with 10,000 
events collected; (Error bars) SEM for data sets n = 3.  (D) 
BG01V/NHEJ-red cells were infected with Ad-SceI at an MOI of 30 at 
48 h after nucleofection and collected 24 h later. (Columns) Relative 
NHEJ levels was normalized to β-actin; (Error bars) SEM for data 
sets n = 3. Fold (x) indicates changes in the relative repair levels 
when compared to the hESC sample. Statistical significance is 
marked between Ad-SceI infected samples. 
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 vector (Golding et al. 2009a) showed a 1.3-fold higher level of “HiFi” NHEJ compared to 
in vitro derived astrocytes (data not shown).  
 
In order to verify the results that digestion with PsiI is indicative of “HiFi” NHEJ, 
DNA sequencing of the PCR cloned products was performed.  DNA sequencing revealed 
that 50% of the amplified DNA contained the specific site for PsiI digestion (Table 6-1), 
which correlates well with the ~55% value obtained previously (Figure 6-4A).   Other 
alterations found due to deletions or lack of fill-in of nucleotides by polymerases is shown 
as well.  Similarly, cloning and sequencing for the U87 clone was performed as well and 
shown to correlate with the percent of “HiFi” repair from the PsiI and gel analysis (data  
not shown).  Altogether, “HiFi” repair appears to correlate with cell cycle and replicative 
growth and was 2-3 fold higher in hESCs than in astrocytes and human glioma cells.  
 
 
PARP-1 induces DSBs in hESCs but does not affect NHEJ 
Our data suggest that rapidly dividing hESCs may rely extensively on a 
microhomology-mediated form of NHEJ, therefore, inhibiting this pathway may reveal the 
process responsible for NHEJ repair in hESCs. This may be accomplished using the 
recently described PARP1/2 inhibitor, KU-54936 (PARPi), since PARP-1 has been 
suggested to be involved in alternative forms of NHEJ (Wang et al. 2006; Menear et al. 
2008).  We show that the PARPi induces DSBs in hESCs and NPs leading to increased γ-
H2AX foci formation (Figure 6-5A and B).   Despite the efficacy of the drug there is no  
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Figure 6-4. High Fidelity NHEJ is up regulated in hESCs .   (A)  
BG01V, NP, and astrocyte/NHEJ-red cells were infected with Ad-SceI 
and collected 24 hrs after infection. DNA was amplified and digested 
with PsiI endonuclease or not. (Columns)  “HiFi” NHEJ levels were 
determined by the relative level of the digested portion (PsiI-sensitive) 
of the PCR DNA fragment as a fraction of uncut DNA; (Error bars) 
SEM for data sets n ≥ 3. Fold (x) indicates changes in the relative 
repair levels when compared to the hESC sample. *p < 0.05: **p < 
0.01; ***p < 0.001. (B) hESCs, NPs, and astrocytes samples from 
graph were visualized on 9% polyacrylamide gel stained with 
ethidium bromide. (C) DNA sequencing reveals the modifications to 
the repair site after Ad-SceI infection.  The sequence obtained at the 
repair site, the missing nucleotides, as well as the frequency out of 28 
clones is displayed.  
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Uncut Sequence 
CCATTACCCTG TTATCCCTACTCGAGCCATGGCTAGGGATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCC 
  
        “HiFi”   
         TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
 
P1     TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P2     TTTAAACTACGGGATCCATTACCCTGTTA------CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P3     TTTAAACTACGGGATCCATTACCCTGTTATA--CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P4     TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P5     TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P6     TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P7     TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P8     TTTAAACTACGGGATCCATTACCCTGTTATA--CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P9     TTTAAACTACGGGATCCATTACCCTG--TATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P10   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P11   TTTAAACTACGGGATCCATTACCCTGTTA----ACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P12   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P13   TTTAAACTACGGGATCCATTACCCTGTTA----ACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P14   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P15   TTTAAACTACGGGATCCATTACCCTGTTAT----CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P16   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P17   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P18   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P19   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P20   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P21   TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P22   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P23   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P24   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P25   TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P26   TTTAAACTACGGGATCCATTACCCTG--TATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P27   TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
P28   TTTAAACTACGGGATCCATTACCCTGTTAT----CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG 
 
TAA3.61TTA
AT7.12TTA---A     
A7.12TTATA -
AA7.12TTAT---
T7.12- TATAA    
TT17.95---ATAA     
Non-HiFi
5014TTATAA  
HiFi
Deletion%n=28Sequence
----
Table 6-1. Sequencing of NHEJ repair site.  
DNA sequencing reveals the modifications to  
the repair site after Ad-SceI infection.  The  
sequence obtained at the repair site, the  
missing nucleotides, as well as the frequency 
out of 28 clones is displayed. 
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 effect on the repair of the Sce-I induced break on the hESCs (Figure 6-5C).  Thus, in 
hESCs PARP-1 did not affect the properties or frequency of NHEJ repair.  This data 
correlates with previously published experiments in mESCs where PARP-1 deficient cells 
were shown to have the same HRR and NHEJ repair levels as wild type cells (Yang et al. 
2004). 
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Figure 6-5.  PARPi induces DSBs in hESC but does not 
contribute to NHEJ.  (A) Images and (B) graphical depiction of γ-
H2AX foci in hESCs and NPs after cells were treated with PARPi at 3 
μM for 16 hrs.  (C) BG01V/NHEJ-red cells were treated with PARPi 
for 16 h and collected at 24 h after Ad-SceI infection. (Columns) 
Relative NHEJ levels was normalized to β-actin; (Error bars) SEM for 
data sets n = 3. No statistical significance was found between treated 
and untreated sample. 
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 Discussion 
    
Our previous results suggest that ATM plays a critical role in the formation and 
maintenance of repair foci in astrocytes. Furthermore, treatment of astrocytes with DNA-
PKi in part inhibited the rate of IRIF resolution. This finding indicates that while DNA-
PKcs is involved in later steps after marking the DNA break, ATM is vital for the initial 
signaling, formation and maintenance of repair complexes necessary for efficient DSB 
repair.  
 
Current discoveries show that there may be more than one type of NHEJ, with the 
predominant pathway utilizing DNA-PKcs and backup pathway utilizing Histone H1, 
PARP-1, and a Ligase III/XRCC1 complex (Iliakis 2009 ).  This backup pathway appears 
to be inhibited by proteins other than those in the more commonly recognized D-NHEJ 
pathway such as Ku70/80 and DNA-PK (Bennardo et al. 2008).  It is possible that there is 
a change in the pathways as cells differentiate and the backup form of repair is more 
prevalent in embryonic stem cells. Interestingly, we show DSBs caused by the 
endonuclease I-SceI are repaired in hESCs with greater fidelity than NPs, astrocytes and 
glioma cells.  It is also apparent that the extent of high fidelity NHEJ decreases through 
differentiation.  This data is supported by the down regulation of the mRNA of many DNA 
damage response proteins as cells differentiate, indicating that repair factors are expressed 
differently through differentiation (Maynard et al. 2008). 
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  Since the hESCs have slower repair kinetics this may indicate that B-NHEJ is used 
since for the B-NHEJ repair kinetics is slower than in the D-NHEJ (Iliakis 2009). In 
addition the B-NHEJ pathway occurs more often in the S/G2 phase of the cell cycle or in 
cells rapidly proliferating (Wu et al. 2008).  It is well established by our data as well as 
others that hESCs are predominantly in the S/G2 phase of the cell cycle and do not have a 
functional G1 checkpoint (Becker et al. 2006).  This checkpoint does however become 
prevalent in the NP stage of the cell cycle.  We have also shown inhibitors of DNA-PK and 
ATM are more potent in terminally differentiated cells.  These inhibitors may be 
ineffective since the backup pathways may not utilize DNA-PK, which interacts directly 
with ATM.  Also the utilization of the backup pathway with slower kinetics may allow for 
polymerases such as µ and λ to fill in nucleotide overhangs and ensure a higher accuracy 
of repair. This is corroborated with the increase in fidelity of hESCs compared to 
astrocytes. An explanation for high fidelity NHEJ in S or G2 cells is the presence of a 
sister chromatid. There is data showing close physical cohesion of sister chromatids that 
might play an important role in stabilizing the ends of the DSB and preventing degradation 
or exonuclease activity that leads to deletions in NHEJ (Miyazaki and Orr-Weaver 1994). 
 
It was not surprising that PARPi had no effect alone or in combination with ATMi 
on NHEJ in hESC since this observation was made in mESCs previously (Yang et al. 
2004).  PARP-1 exerts its effects by modifying chromatin factors, such as Histone 1, at 
single or double strand breaks to enhance repair (Rosidi et al. 2008).  One possible 
explanation for the lack of an effect of ATMi and DNA-PKi in hESCs is that ESCs are 
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 globally euchromatic and have elevated global transcription compared to NPs (Meshorer et 
al. 2006; Efroni et al. 2008).  Therefore, they would not require modification of chromatin 
for repair.  We have previously shown that the ATR is able to commandeer ATM’s role in 
DSB repair signaling in hESCs (Adams et al.) and similarly, ATM may only be required 
for a subset of DSBs associated with heterochromatin (Goodarzi et al. 2008).  In summary 
this data shows that hESC may employ the use of “HiFi” NHEJ in which PARP-1 or 
DNA-PKcs does not control factors responsible for nucleotide microhomology fill-in or 
resealing. 
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Chapter 7   Conclusions 
  
 
 
 
Understanding genomic stability has not only been imperative for developing 
cancer therapeutics such as the ATMi and DNA-PKi but is now becoming a focus for 
regenerative medicine.  Observations that stem cells develop aneuploidy in vitro and that 
stem cell transplants can result in aberrant cell signaling leading to tumor formation 
provide clinical application to studies investigating these cell’s DNA damage responses 
(Amariglio et al. 2009). Previous studies show the spontaneous rate of mutation is 
decreased in embryonic cell lines compared to differentiated progeny (Cervantes et al. 
2002; Hong et al. 2007).   The DSB is the most lethal from of DNA damage and leads to a 
massive cellular response.  The aim of this study was to advance current perspectives as to 
how cells orchestrate the DNA DSB damage response from the embryonic state and from a 
terminally differentiated state.  
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Initial experiments were aimed at developing methods for analyzing cells 
throughout differentiation.  We combined both others work through in vitro and in vivo 
methods to direct embryonic stem cells to neural NPs and then to astrocytes (Seth et al. 
2004; Lawrence et al. 2006; Dhara et al. 2008b).  As cells differentiated there was a 
decrease in the rates of proliferation, indicating that there were fewer cells in S and G2.  
Initial repair studies provided the methods and relevant doses of irradiation to accurately 
study repair in ESCs.  Here we observed that while hESCs were predominantly in the S 
and G2 phase of the cell cycle, they lacked a G1 checkpoint, which has also been observed 
in primate and mESCs as well (Koledova et al.; Fluckiger et al. 2006). It is likely that 
hESCs would therefore utilize HRR as a main mechanism of DSB repair since HRR is 
considered to be most important in the late S and G2 phases (Rothkamm and Lobrich 
2003).  Therefore this system analyzes the effects of epigenetic and cell cycle effects on 
repair since all cell populations are identical at the genetic level.   
 
 In order to test this hypothesis both the IRIF repair kinetics of γ-H2AX and 
RAD51 were analyzed.  hESCs showed a slower rate of resolution of the IRIF.  This delay 
in resolution is likely due to the form of repair and cell cycle checkpoints status.  To 
directly look at the use of HRR the cells RAD51 foci formation and resolution were 
observed. Here we show a strong dependence of hESCs on HRR which diminishes upon 
differentiation.  This corroborates the γ-H2AX IRIF resolution because HRR is a more 
intricate and slower form of DSB repair.    
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The most exciting finding was that ATM seems to not be important in the 
resolution of DSBs in hESCs, but becomes imperative for repair in astrocytes.  This was 
displayed by showing that ATMi rapidly dissolves repair foci in astrocytes but has no 
effect on hESCs.  In astrocytes it was possible that the repair was occurring faster in ATMi 
treated samples since the foci disappeared at a faster rate than those not exposed to drug. 
However, by adding the drug before and after IR we showed that this is not the case.   
Since ATM was not needed for repair it was possible that ATR was the more important 
DNA repair signaling kinase in this cell system.  One possible reason for this is that ATR 
has repeatedly been shown to be important for initial signaling after replication forks stall 
leading to DSBs.  Also ATR is an essential gene whereas ATM is not, indicating a more 
vital role during development.   
 
Similarly, cell cycle features point to a role for ATR-dependent DSB repair.  ATR 
is more strongly linked to the G2/M checkpoint which is robust in hESCs, while ATM 
correlates with initiating the G1 checkpoint which is absent in these cells.  It is possible 
that ATM activity is repressed causing a G1 deficiency in hESCs and ATR still facilitates 
signaling for hESCs which are predominantly in S/G2.   It is important to note others have 
demonstrated that ATM is not entirely dispensable in ESCs since it has roles in regulating 
cell survival and telomere length (Song et al.).   When hESCs are exposed to IR they do 
not pause at the G1/S checkpoint but instead continue through the S-phase replicating their 
DNA.  This phenomenon is known as radio-resistant DNA synthesis, which is also a 
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 property of cells with ATM mutations or deletions (Abraham 2001). As mentioned earlier, 
A-T cells show strong G2 checkpoint signaling regardless of the type of damage unless the 
insult occurs in cells already in G2 (Beamish and Lavin 1994).  The cell cycle data shown 
here therefore supports the idea that hESCs are similar to A-T cells.   
 
Finally it is likely that ATR is responsible for the signaling in hESCs since ATR 
and ATM have been shown to act as backup kinases for each other in specific contexts 
(Abraham 2001).  Currently there are no small molecule inhibitors that target ATR; 
therefore it was necessary to examine the effects of inhibition on ATR by siRNA.  ATR 
was reduced by siRNA treatment and a reduction in γH2AX was observed.   This is the 
first report of ATR being the main kinase responsible for IR induced DSB repair.  
However, using the specific inhibitors we showed that DNA-PK and ATM were crucial for 
IRIF resolution in NPs and astrocytes.  While ATM inhibition caused disabling of the 
repair complexes, the DNA-PK inhibitor only inhibits resolution after the repair complex 
formation indicating ATM acts upstream of DNA-PK.  
 
 
To verify these findings and further explore the role of NHEJ in hESCs we 
modified a previously described repair assay (Willers et al. 2006).   This is the first time 
direct evidence shows by a defined cassette that Oct3/4+ ESCs utilize NHEJ as a repair 
mechanism.  Using the cassette it was also possible to examine the kinetics of DSB repair 
through NHEJ exclusively through PCR assays or by examining DsRed fluorescence.   
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 Here we saw a significant difference between hESCs and astrocytes in formation of the 
PCR product after NHEJ and a greater percentage of cells producing DsRed fluorescence 
in the astrocytes as compared to stem cells.  Utilizing the specific ATM and DNA-PK 
inhibitors we show that the drugs increase their inhibition of NHEJ as cells progress to 
terminal differentiation. This is expected due to the previous data showing that resolution 
of repair was completely independent of ATM activity. This raises the question, what is 
involved in the initial signaling for NHEJ repair?  Current dogma holds that ATR is only 
imperative for HRR while ATM is involved in signaling for both pathways, however it is 
likely that ATR activation affects proteins involved in NHEJ (Valerie and Povirk 2003; 
Wang et al. 2004).  It is important to note that ATR was recently shown to direct 
nucleotide excision repair in S phase cells (Auclair et al. 2008). 
 
We have also devised the repair assay to allow for an easy readout as to the extent 
of high fidelity NHEJ by PsiI digestion.  This assay is the first to quantify the extent to 
which the fidelity of NHEJ deceases as cells differentiate.  This may be counter intuitive 
seeing as the astrocytes only have NHEJ as a form of repair, but what may be most 
important is the fast ligation of the DNA ends back together, rather than the maintenance 
of genomic integrity since they will not divide.  The fact that hESCs repair their DNA with 
greater fidelity is also supported by the cloning of individual PCR products and sequencing 
which shows a greater number of sequences in hESCs that have increased repair fidelity in 
NHEJ.   
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  It is thought that hESCs require the highest fidelity of DNA repair given 
that they will produce all cells of the organism.  Two other factors, apoptosis and cell cycle 
checkpoints, are very important regarding the maintenance genetic information.  Others 
have shown that these hESCs are exquisitely sensitive and readily undergo apoptosis as a 
means to clear damaged cells and maintain those with pristine genetic material (Hong et al. 
2007; Stambrook 2007).  This study also defines not only the cell cycle checkpoint 
mechanisms but why there may be an abrogated G1 checkpoint.  Since cells are able to 
continue and cycle through the S and G2 stages there will be a sister chromatid available to 
either allow for homologous sequence to be used for HRR or stabilize the break so “HiFi” 
NHEJ  is able to take place.  Also, proteins involved in the high fidelity forms of repair 
may be upregulated in the S and G2 phases of the cell cycle (Branzei and Foiani 2008). 
 
Altogether our results have shown that hESCs rely heavily on HRR in addition to a 
high fidelity form of NHEJ which fills in nucleotide overhangs to maintain genomic 
integrity. This indicates that stem cells utilize the most accurate mechanisms possible to 
maintain genomic stability. Not only is there a strong dependence on HRR which is able to 
make a perfect copy of the DNA that was damaged from a homologous sequence, but also 
does not depend on DNA-PKcs for NHEJ.  This repair shows slower repair kinetics and a 
higher degree of repair fidelity.  This increased repair fidelity is probably due to 
polymerases that are able to fill in slight overhangs caused by the damaging agent.  
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